weighted_quality_rating,weighted_completeness_percent,id,schema_version,completeness_percent,quality_score,quality_rating,title,weighted_quality_score,pid,error_percent,publisher,weighted_error_percent
Not Rated,22.22,0092dc60-a0af-4d45-801c-b888210d6609,1.1.7,26.19,47.98,Not Rated,National Joint Registry - Primary Elbow Replacement dataset,45.23,b06415af-9151-4ccc-83a1-ab859943fb2b,30.23,ALLIANCE > HQIP,31.75
Bronze,60.32,0121c132-5be6-414e-853b-885ff301854f,1.1.7,69.05,72.89,Bronze,PTCL Biobank,69.05,19fa25a7-c15d-441c-b635-ad49043e7a96,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Bronze,60.32,01470238-7a17-47a5-a131-17178ba26a0a,1.1.7,69.05,74.06,Bronze,Human Developmental Biology Resource (HDBR),69.84,399a6d67-7577-4476-a3b6-4bbceb5a8ff7,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,46.03,0150353c-d33d-4af0-b177-8ef0adf867f4,1.1.7,52.38,64.56,Not Rated,Estimating Chronic Respiratory Disease burden in adults in Asian LMICs,61.11,56130df6-1880-4600-a7a4-afa9a4bcc895,23.26,HUB > BREATHE,23.81
Not Rated,22.22,0217114b-6847-4aae-9d76-4d52acea2bcc,1.1.7,26.19,46.81,Not Rated,Paediatric Intensive Care Audit Network - core dataset (admission),43.65,4ca76471-6970-4ad4-87c7-fae77a98cbf5,32.56,ALLIANCE > HQIP,34.92
Bronze,60.32,0315886c-f34a-4f1d-8f76-2dfa80a6e949,1.1.7,69.05,74.06,Bronze,Cam-UroOnc Biorepository,69.84,21044030-1cd5-46b1-b072-c9959fd330b4,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,23.81,039c0b29-63f6-4ce9-8d89-87012a52e44f,1.1.7,28.57,48.0,Not Rated,The Leicester City and County Chronic Kidney Disease Cohort,45.24,4dfec37d-dd24-465f-85ea-30209aff3a26,32.56,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,33.33
Bronze,68.25,03fb3b18-4419-44f7-a035-9ddfecfcadfc,1.1.7,59.52,64.64,Not Rated,COVIDsortium,67.46,529f126b-660c-4c31-aeb2-765dac1d9df0,30.23,OTHER > UNIVERSITY COLLEGE LONDON,33.33
Not Rated,14.29,0477b06f-cbed-4949-982e-ce248a47ed1a,1.1.7,16.67,38.57,Not Rated,SOLUS,37.3,e653b264-3e44-4ed1-a376-86df45db7f72,39.53,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.68
Not Rated,22.22,04b1648d-eeb7-4072-8dd2-806c3ae4e20d,1.1.7,26.19,45.66,Not Rated,National Cardiac Audit Programme - Myocardial Ischaemia National Audit Project (MINAP),42.86,3558f8a1-6d52-4b59-b513-51c068095bc2,34.88,ALLIANCE > HQIP,36.51
Silver,96.83,04f22c93-53df-440a-a71a-50d6827450bc,1.1.7,92.86,83.64,Silver,North West London COVID-19 Patient Level Situation Report (NWL COVID19 SITREP),84.13,ed08c844-343e-44fa-a02d-3ad5ecf25184,25.58,HUB > DISCOVER NOW,28.57
Gold,100.0,05716e41-9842-4c07-8ddd-af9f9231e056,1.1.7,95.24,88.32,Gold,Bowel Screening Wales,89.69,9f29d47e-4e9a-41b8-b7bc-5ef3570294ef,18.6,ALLIANCE > SAIL,20.63
Gold,100.0,05a0baf4-72ea-4e02-b4fb-64c37bb1eb0e,1.1.7,95.24,87.16,Gold,COVID-19 Shielded People list,87.3,dc22db56-8791-4e96-9ce6-6b6a58b1241f,20.93,ALLIANCE > SAIL,25.4
Not Rated,50.79,05eadf79-02a7-4c1f-b1be-93694172a9b3,1.1.7,59.52,69.3,Bronze,IBD Registry,65.08,a406d06b-350e-4392-ab4e-b1012e422a34,20.93,HUB > GUT REACTION,20.63
Bronze,60.32,0664f988-276e-4268-af43-1986a3101f38,1.1.7,69.05,74.06,Bronze,INCA Trial,69.84,edd55990-a616-4a9c-a4a2-38af136a349b,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,47.62,0692d86c-1f24-43a4-9508-005d00bd7259,1.1.7,54.76,66.91,Bronze,CuT-AsthMa: Culturally tailored school-based intervention for asthma in Malaysia,62.7,009bcb87-05f3-46e6-8866-7e4df698cb19,20.93,HUB > BREATHE,22.22
Bronze,60.32,069c213c-eb04-463e-a300-7614c03cf623,1.1.7,69.05,74.06,Bronze,HCV Research UK,69.84,01492322-9b33-41cc-9f51-484024e45878,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Gold,98.41,06dee089-8c10-4a8b-aa94-7cb699dc3c80,1.1.7,92.86,83.64,Silver,"OMOP dataset: Hospital COVID patients: severity, acuity, therapies, outcomes",86.5,0eb789bb-0047-46ac-83ff-631f31e98da0,25.58,HUB > PIONEER,25.4
Not Rated,14.29,0711cc7e-80d5-4781-a1ab-2637ea176ceb,1.1.7,16.67,38.57,Not Rated,Millennium Clinical Events,37.3,5f45bcd1-970b-44ba-8ae2-0fb49b85ffa9,39.53,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.68
Silver,71.43,0715a950-3999-46d8-a646-6496866638a1,1.1.7,80.95,82.34,Silver,Prospective Observation of Fibrosis in the Lung Clinical Endpoints,76.98,bb8de9d2-cc38-4c40-b104-ffd167f64f76,16.28,HUB > BREATHE,17.46
Not Rated,31.75,07b82dd5-adc3-42c5-8a60-914042b5bc40,1.1.7,33.33,51.55,Not Rated,Exome sequencing,51.59,2ddf0659-f05a-4f1c-b558-63a96e5b49f7,30.23,UK Biobank,28.57
Silver,84.13,07e3ac82-a38d-45f3-9933-07439f6a761d,1.1.7,76.19,74.14,Bronze,The impact of COVID on hospitalised patients with COPD; a dataset in OMOP,78.57,323dc330-aad9-472a-b579-ab66f5f75906,27.91,HUB > PIONEER,26.98
Silver,88.89,08846261-45f0-4bcf-9801-fe785dcef1c9,1.1.7,80.95,77.69,Silver,Careers Wales dataset,80.95,e4004e0e-6adb-4b11-82c2-af0caf61d751,25.58,ALLIANCE > SAIL,26.98
Not Rated,17.46,08a29778-afac-4ae0-86fc-5ca544d53874,1.1.7,21.43,42.11,Not Rated,Walker Study Data,40.48,245bffa9-07c3-40b6-916b-161062cdf674,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Silver,82.54,0942304f-8b91-4258-af9c-3a1801c7e79f,1.1.7,73.81,72.95,Bronze,The acute presentation of pregnant women to non-maternity Emergency departments,77.78,86632207-1e57-4272-b178-ea069a13cae1,27.91,HUB > PIONEER,26.98
Not Rated,22.22,09586db0-4da4-47f8-9434-13cbd2da2bb9,1.1.7,26.19,46.81,Not Rated,Paediatric Intensive Care Audit Network - customised data collection,43.65,6c78af2c-3898-435e-b1f4-e6a44682dc71,32.56,ALLIANCE > HQIP,34.92
Silver,85.71,0970a6b2-d142-4c18-ae6e-23e21779e22c,1.1.7,78.57,76.5,Silver,Personal Demographic Service,80.16,f8be6d46-61de-4ed3-b127-76cdf92209d0,25.58,ALLIANCE > NHS DIGITAL,25.4
Bronze,60.32,097cc6bd-ce98-47ec-a73d-5d2c250f2697,1.1.7,69.05,74.06,Bronze,ICON9 Trial,69.84,1fdf266c-d5d8-418d-a423-81265da540a2,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,57.14,0985f58b-87e0-42d2-9ee7-efd618abcd51,1.1.7,66.67,74.03,Bronze,Development of spirometry predictive values for Indian population,68.25,59521b01-6adb-4dd3-8b40-dbeb51171e4f,18.6,HUB > BREATHE,20.63
Bronze,61.9,09d6c72a-7d11-4116-8cf8-6b0da9724bd0,1.1.7,69.05,77.55,Silver,National Records of Scotland (NRS) - Births Data,73.02,3b87eef0-bfb6-4bf4-84b9-29880197fec9,13.95,ALLIANCE > PUBLIC HEALTH SCOTLAND,15.87
Bronze,58.73,09e8e407-82b4-4ed4-b296-53810472cbe9,1.1.7,69.05,76.38,Silver,Reasons for delay in seeking care for pneumonia in children under five,69.84,46f50b9b-b8e2-4ff1-a1b3-779174c3d032,16.28,HUB > BREATHE,19.05
Not Rated,22.22,0a418d30-c13c-404a-9f4c-39334d889b9c,1.1.7,26.19,46.81,Not Rated,Paediatric Intensive Care Audit Network - core dataset (transport),43.65,45310176-6331-4bdd-bc53-d9194e212a35,32.56,ALLIANCE > HQIP,34.92
Gold,100.0,0abfceb7-5a56-4559-b0d4-88326e0331a3,1.1.7,95.24,87.16,Gold,Pathology Data from WRRS,87.3,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,20.93,ALLIANCE > SAIL,25.4
Bronze,60.32,0b7ea326-fc05-4aca-a962-3f93128b91d1,1.1.7,69.05,72.89,Bronze,HPB Biobank,68.25,ebe6c9dd-fb95-4301-a929-c21b8077753a,23.26,ALLIANCE > TISSUE DIRECTORY,23.81
Not Rated,22.22,0bb202c7-80e8-4532-8042-1351576e6c94,1.1.7,26.19,45.66,Not Rated,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - clinical audit,42.86,3afbb83d-d47b-43b3-a202-0d3081e5d294,34.88,ALLIANCE > HQIP,36.51
Bronze,60.32,0c50801d-1079-4879-b608-5e8f112b313f,1.1.7,69.05,72.89,Bronze,Tissue Access for Patient Benefit (TAPb),68.25,35985f8e-f01a-41cc-a9e2-30299d3d6eed,23.26,ALLIANCE > TISSUE DIRECTORY,23.81
Not Rated,17.46,0c74238f-58b4-42d4-a97a-94737d75a897,1.1.7,21.43,42.11,Not Rated,Fife Microbiology: Isolations,40.48,79086e92-cbbf-4615-b642-bc65d8a3bc6d,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Not Rated,46.03,0c98200b-48b5-418a-b8d0-a7708abc1f39,1.1.7,47.62,54.05,Not Rated,Mental Health Services Data Set - Community,54.76,f3bb6a68-2c32-40a7-9a79-61a718068893,39.53,ALLIANCE > NHS DIGITAL,36.51
Bronze,57.14,0d0ce21e-afc1-4d9f-bf54-e0545363a0cc,1.1.7,66.67,74.03,Bronze,Research on use of an online learning platform on under-five pneumonia,68.25,a3d85fd2-9df3-4f6e-9035-0830a3488ddb,18.6,HUB > BREATHE,20.63
Bronze,63.49,0d6ab9af-c43b-490d-b39c-2d72de46a661,1.1.7,71.43,75.25,Bronze,The Cleft Collective,71.43,12288034-00a4-47a8-a779-1cf7a55270e4,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,60.32,0d70b5c8-da5d-49c5-8ff5-0bdc7b5f6306,1.1.7,69.05,74.06,Bronze,MRC Brain Banks Network,69.84,6f1b9a4e-2367-47f1-a985-3ed9bf3a7211,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,60.32,0d79e0d8-9b3d-4450-9c34-0539673dc9a5,1.1.7,69.05,74.06,Bronze,Leeds NIHR Biomarker Research Tissue Bank,69.84,8648d251-6186-4383-82fc-c036a87c3842,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,22.22,0d89c503-1c79-4e2a-baf6-02f12e68805b,1.1.7,26.19,47.98,Not Rated,National Neonatal Audit Programme - clinical audit,45.23,382e897a-77cf-46ca-8d44-d79449ab61df,30.23,ALLIANCE > HQIP,31.75
Bronze,79.37,0ddcb454-2372-4180-9ba0-a7e1896d4fe2,1.1.7,73.81,69.47,Bronze,Real Time Data Network (RTDN),72.22,616c4488-65a5-4608-a187-0c6bc78b359a,34.88,HUB > DATA-CAN,34.92
Bronze,79.37,0e07413c-892c-4f06-bd22-2a917eb5c905,1.1.7,71.43,69.44,Bronze,Cancer Registration Data,73.02,2ed7bbbc-80db-46c2-a45b-632dda40794b,32.56,ALLIANCE > NHS DIGITAL,33.33
Not Rated,77.78,0e6e6ed5-ab81-4d7f-b06a-768bf33357ca,1.1.7,64.29,56.57,Not Rated,Mental Health Minimum Dataset v4 (Sensitive) Episodes,61.11,29c61f09-c4a1-425f-9bbc-888c23d99516,51.16,ALLIANCE > NHS DIGITAL,55.56
Not Rated,17.46,0e80170d-de4f-4349-a879-c54a70262736,1.1.7,21.43,42.11,Not Rated,Tayside Bowel Screening Dataset,40.48,00201dde-1faf-41d3-b282-5c24c0ca3697,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Not Rated,47.62,0e8546e9-c841-4a99-a3f8-bb9020c6782c,1.1.7,54.76,66.91,Bronze,Developing and Evaluating Interventions to Improve Asthma Care,62.7,d57d7956-d13e-49c4-bb31-889b8e560596,20.93,HUB > BREATHE,22.22
Bronze,60.32,0ecedaa2-e8f5-4eb2-ad3f-fc2ce433fc36,1.1.7,69.05,74.06,Bronze,Cardamon Clinical Trial Samples,69.84,c0dcceca-c8cf-4269-a0e0-0c18b6ba2de1,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,60.32,0faa4c3e-edf5-4ae8-9b26-c59c98e26b57,1.1.7,69.05,74.06,Bronze,UKALL14 Trial,69.84,b5533cb5-0c59-495b-9b11-3c401daeb958,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,77.78,0fc61ace-397d-4489-9e62-77f88082e775,1.1.7,64.29,56.57,Not Rated,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Events,61.11,9c8bd383-b117-4167-a25c-9e15fa5ec1c6,51.16,ALLIANCE > NHS DIGITAL,55.56
Silver,95.24,1046b837-c4d9-4688-a06e-d7b32d37a161,1.1.7,90.48,83.61,Silver,IBD NIHR BioResource: Health and Lifestyle Questionnaire,85.72,18bfe765-5733-41f3-8114-0a1ec2524b5b,23.26,HUB > GUT REACTION,23.81
Not Rated,15.87,1092c90a-d3d5-4904-97ba-1861cfaddb65,1.1.7,19.05,37.43,Not Rated,CDE Clinical Events,36.51,e3b36044-e1fb-418b-946a-b83626bf2e3f,44.19,ALLIANCE > BARTS HEALTH,42.86
Not Rated,17.46,10b10bc5-ce28-4cc0-b006-2a0e6d03a72d,1.1.7,21.43,40.95,Not Rated,CDE Patient Demographics,38.89,209d7fae-0521-4d07-8a4d-e0843a46a107,39.53,ALLIANCE > BARTS HEALTH,39.68
Not Rated,22.22,11571357-b9fc-45ed-ab40-3bb3d7443245,1.1.7,26.19,47.98,Not Rated,National Audit of Dementia Round 4 - carer experience survey,45.23,3b5907da-256d-49a3-b24b-00893afe8bdd,30.23,ALLIANCE > HQIP,31.75
Not Rated,22.22,12690263-f5d3-435b-9582-de1a88064e1e,1.1.7,26.19,47.98,Not Rated,National Vascular Registry Audit Carotid Lower Limb Amputation clinical dataset,45.23,03e77b9d-57b8-44d5-8d64-9b1325958b22,30.23,ALLIANCE > HQIP,31.75
Not Rated,22.22,12c5b83c-6e4a-442e-b6c2-2f6b7165fe6b,1.1.7,26.19,47.98,Not Rated,National Joint Registry - Revision Hip Replacement dataset,45.23,4b8286e2-c4e4-4db4-8fd9-5f1c8b4e56de,30.23,ALLIANCE > HQIP,31.75
Bronze,60.32,12dba445-dfa9-46af-abc0-5bd3701061a7,1.1.7,69.05,72.89,Bronze,UK primary Sjogren's syndrome Registry,69.05,38fe1a10-ebf9-4dc1-8c35-2e7b33b1f6b5,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Bronze,60.32,1406c52a-e5d6-4c57-883d-62e405eb604a,1.1.7,69.05,72.89,Bronze,Manchester Eye Tissue Repository,69.05,47fc8f03-eba1-4efa-ae3e-148a76b56517,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Silver,90.48,142f3390-95eb-49be-bc8c-1a752a7d308e,1.1.7,83.33,78.88,Silver,Scotland Accident and Emergency,80.96,,25.58,ALLIANCE > PUBLIC HEALTH SCOTLAND,28.57
Not Rated,22.22,148a3896-e4ed-48ef-8643-48df726041e1,1.1.7,26.19,46.81,Not Rated,Paediatric Intensive Care Audit Network - core dataset (referral),43.65,79ae4881-6223-471a-a278-6b2d3b84f971,32.56,ALLIANCE > HQIP,34.92
Silver,100.0,148ebbaa-28f4-42e0-a27f-8587e516c3bf,1.1.7,95.24,84.83,Silver,Cystic Fibrosis Patient Sweat Tests,82.54,34f0c2bd-d42e-4441-a89b-e0e384f12afa,25.58,ALLIANCE > CYSTIC FIBROSIS TRUST,34.92
Gold,100.0,15805559-2115-4822-b91f-635de36fb289,1.1.7,95.24,87.16,Gold,Active Adult Survey,87.3,1eb67fd5-33f6-49dd-a43d-854fff9f25f5,20.93,ALLIANCE > SAIL,25.4
Silver,88.89,1584af1e-9683-4727-8c9b-9bea8beaa68d,1.1.7,80.95,75.36,Bronze,UHB 2020 Winter Society of Acute Medicine Benchmarking Audit,77.78,5bf9bf39-3cd7-4a54-994b-9914405f945e,30.23,HUB > PIONEER,33.33
Gold,100.0,15efea36-d022-495c-a5b6-90f51631a643,1.1.7,95.24,84.83,Silver,GENOMICS ENGLAND 100K QUICK VIEW,87.3,4cc5ed33-3190-4f80-953b-cabd5a2b1c7c,25.58,GENOMICS ENGLAND,25.4
Silver,88.89,1638cce2-12f5-410b-9624-86d2f407c502,1.1.7,83.33,78.88,Silver,COVID-19 Clinical Information Network (CO-CIN),78.57,84336be3-23bd-466e-b29b-df48db897665,25.58,ALLIANCE > ISARIC 4C,31.75
Bronze,63.49,16445ebd-bd45-4ded-a7ae-05f33f676598,1.1.7,71.43,75.25,Bronze,MFT Biobank,71.43,d17efe5d-325f-4fcf-b25e-87d1f6269bea,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,57.14,164bf6c1-79f2-4ada-98f6-85b7113d4d20,1.1.7,64.29,75.17,Bronze,Child Health Systems Programme - School,71.43,2c31cb1c-2b3d-40c5-b8d4-bf0b81f089b4,13.95,ALLIANCE > PUBLIC HEALTH SCOTLAND,14.29
Bronze,60.32,167cc04b-23b8-4a9e-9ff9-6c8e07d6a561,1.1.7,69.05,74.06,Bronze,Cambridge Blood and Stem Cell Biobank,69.84,c51ab59a-33ce-4145-a642-7f3f96bca545,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,14.29,172242ce-a1c5-4915-9c71-686f6e7d5789,1.1.7,16.67,38.57,Not Rated,ARIA Medonc,37.3,88eb839c-bc51-45f0-b15e-ea89bba9ffca,39.53,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.68
Silver,88.89,1785cc1a-ace0-4980-8352-5977b2b72969,1.1.7,80.95,75.36,Bronze,UHB 2019 Summer Society of Acute Medicine Benchmarking Audit,77.78,5acfadf9-21a7-4517-a1b2-620d20469611,30.23,HUB > PIONEER,33.33
Bronze,60.32,17cd75a2-e2b5-440c-89b1-22c9f3b03a03,1.1.7,69.05,72.89,Bronze,IoN Trial,69.05,e10a660d-b84c-475f-abd4-024dd1af7a5d,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Not Rated,44.44,17ff9515-8296-435b-a50e-014168714689,1.1.7,52.38,63.4,Not Rated,Generation Scotland: Scottish Family Health Study,59.52,f4f0ef1a-46cf-4734-8516-3adb0b62ae6d,25.58,ALLIANCE > GENERATION SCOTLAND,25.4
Bronze,57.14,184b973d-ac38-4fc5-8203-f2a244574b4f,1.1.7,66.67,75.19,Bronze,Asthma and COPD: practices and perceptions of GPs in rural India,69.05,c15bc3ad-c053-496b-863f-1d54075d5bd4,16.28,HUB > BREATHE,19.05
Not Rated,22.22,18603ae7-a056-4fd6-a3e5-d32a2440dd26,1.1.7,26.19,46.81,Not Rated,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - case note audit,44.45,24b88d1a-4363-4619-870e-9ba9fc5d09e1,32.56,ALLIANCE > HQIP,33.33
Gold,100.0,1900af1a-bd21-4157-ac48-203eec682073,1.1.7,95.24,85.99,Silver,GENOMICS ENGLAND 100K BIOINFORMATICS DATA,86.51,98999c67-0133-4f11-be95-b84ee5727c84,23.26,ALLIANCE > GENOMICS ENGLAND,26.98
Bronze,58.73,191c1e3f-4eff-41b9-bff1-c6510f7c6c3d,1.1.7,71.43,76.42,Silver,Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II),69.05,25bc9862-5b6c-4dda-80b2-46642d9e518a,18.6,HUB > BREATHE,20.63
Not Rated,22.22,1a0af437-ec80-4db7-9c76-a2418cc8c5c8,1.1.7,26.19,45.66,Not Rated,National Asthma and COPD Audit Programme (NACAP): COPD secondary care clinical dataset,42.86,85b4dc84-88f4-4740-80fa-fa1eb04a0ae6,34.88,ALLIANCE > HQIP,36.51
Bronze,63.49,1a412ff0-6275-4cab-a485-bb76befc7afe,1.1.7,71.43,75.25,Bronze,UK real-world lymphoid tissue bank,71.43,c9f82f86-79e1-4067-932f-5e6dc939006d,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Silver,100.0,1a4b65e9-5241-4081-9cbb-43a8c8c6ea3b,1.1.7,95.24,84.83,Silver,Cystic Fibrosis Patient CFQ-R,82.54,9cf5dbd3-a109-4e8d-b1bb-7e4126bd887f,25.58,ALLIANCE > CYSTIC FIBROSIS TRUST,34.92
Not Rated,46.03,1b80d25c-4f0f-497b-8614-4d1a8c4d1cd3,1.1.7,52.38,65.72,Not Rated,Air Quality Study: An ecological analysis of asthma health outcomes in Malaysia,61.91,95f385b1-4f5c-4a88-8e79-9613acc66938,20.93,HUB > BREATHE,22.22
Bronze,77.78,1b863415-be4e-4229-98c8-8591a802ae72,1.1.7,69.05,69.41,Bronze,Emergency Department (eEMS),72.22,2ba72371-1527-4d8d-94e2-f795e45b9f77,30.23,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,33.33
Silver,90.48,1bc9ccd6-44d0-43db-843a-f9fa293c4090,1.1.7,80.95,71.87,Bronze,Mother-Baby Link for CPRD GOLD,76.19,b734a1b5-37d3-4859-85d4-bf011df2a951,37.21,ALLIANCE > CPRD,38.1
Silver,85.71,1c3f55ec-d6fc-477e-a1b7-4b8dd43323c6,1.1.7,78.57,75.33,Bronze,NIHR BioResource: Health and Lifestyle Questionnaire,78.57,321e3ad6-96b9-4f19-bbc4-d06dfe2a59d5,27.91,ALLIANCE > NIHR BIORESOURCE,28.57
Bronze,84.13,1c84d938-f560-43bf-8df7-5f1ca3a18180,1.1.7,76.19,70.66,Bronze,Covid-19 UK Non-hospital Antibody Testing Results,73.02,a77e52cc-d404-45d6-835f-32e2dc46778a,34.88,ALLIANCE > NHS DIGITAL,38.1
Silver,92.06,1c942123-845d-4c31-9f04-8e044be00e58,1.1.7,85.71,75.41,Bronze,HES Admitted Patient Care data for CPRD Aurum,78.57,ed2de8fe-a204-4a4e-bcfa-9e3ad85e2fee,34.88,ALLIANCE > CPRD,34.92
Not Rated,46.03,1cb397d5-a86d-4354-b1f7-565b7ef5054b,1.1.7,54.76,64.59,Not Rated,Asthma self-management behaviour in Bangladesh and Pakistan,60.31,3b378225-48e1-45fa-b62d-fc4ed4b39bec,25.58,HUB > BREATHE,25.4
Gold,100.0,1d46f920-e253-4e7d-a72a-843d068d3c69,1.1.7,95.24,87.16,Gold,Critical Care Dataset,87.3,1789286a-deaf-49df-88cd-660e92934af6,20.93,ALLIANCE > SAIL,25.4
Not Rated,46.03,1d5e3b05-8ce3-4f80-ae3a-f6031ad8cf69,1.1.7,47.62,54.05,Not Rated,Mental Health Services Data Set - Service Users,54.76,f48ad0a1-f90c-4a81-8c04-b23f2d8baf7a,39.53,ALLIANCE > NHS DIGITAL,36.51
Not Rated,22.22,1da704e3-f5ee-4614-8880-10541637a0b7,1.1.7,26.19,45.66,Not Rated,National Cardiac Audit Programme - National Audit of Percutaneous Coronary Interventions (PCI),42.86,ac7016ce-f7a9-4c71-bebb-6af6efa27844,34.88,ALLIANCE > HQIP,36.51
Not Rated,17.46,1db7ce43-0dc3-4fa9-8bc8-14db16aba508,1.1.7,21.43,42.11,Not Rated,Patient SIMD Postcode,40.48,798567eb-d790-466e-880b-75a1e94ffdf2,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Not Rated,15.87,1e465797-5e54-4667-9120-d373e75be64f,1.1.7,19.05,38.59,Not Rated,Somerset Cancer Registry,37.3,3ec5f1c4-95c0-4b1d-899b-399cec32ad49,41.86,ALLIANCE > BARTS HEALTH,41.27
Not Rated,63.49,1e5aa7d9-9b77-4795-a5bf-effdcd4ae992,1.1.7,52.38,58.75,Not Rated,Community Services Data Set,63.49,5616e0a6-22f1-43a5-a2bd-dcecfa2f3b70,34.88,ALLIANCE > NHS DIGITAL,36.51
Silver,100.0,1e61d0a3-5867-4865-8056-f26afacb1f05,1.1.7,95.24,82.5,Silver,CPRD Aurum,84.92,1d574c14-1af0-490d-9c4e-be88cfd0e345,30.23,ALLIANCE > CPRD,30.16
Bronze,58.73,1fcbb814-10e0-43b7-b383-b5c818090ac8,1.1.7,66.67,71.7,Bronze,NIHR BioResource: SNP imputation data,67.46,39d7ad29-be30-4e12-a7c8-d8757141de85,23.26,ALLIANCE > NIHR BIORESOURCE,23.81
Silver,96.83,208f79dc-2294-4370-8f16-0d0f7bec9d10,1.1.7,92.86,82.47,Silver,Moorfields Eye Image Dataset Release 001,83.34,6bfe44ef-9532-4986-b8a2-9c2cda4a89cc,27.91,HUB > INSIGHT,30.16
Silver,95.24,21b6b27d-fe1b-4e7c-bae6-32d734d28a22,1.1.7,88.1,76.61,Silver,CPRD COVID-19 Symptoms and Risk Factors Synthetic Dataset,79.36,a48c65e2-a4e0-4d05-9e9c-fc84e050dea0,34.88,ALLIANCE > CPRD,36.51
Not Rated,71.43,21cd4b8e-f4f5-44a6-83eb-b7799e98ba55,1.1.7,80.95,69.55,Bronze,South London and Maudsley NHS Foundation Trust (SLaM) Clinical Record Interactive Search (CRIS) platform,65.08,a25a9892-9141-4e78-8415-945ba73da11e,41.86,ALLIANCE > SLaM,41.27
Bronze,85.71,22173802-db99-475e-b95e-d69798734077,1.1.7,78.57,74.17,Bronze,NHS 111 Dataset,75.39,3d6b69dc-cb3c-4b9a-bdea-a798e7d5b5cf,30.23,ALLIANCE > SAIL,34.92
Bronze,63.49,22739526-317f-4b0e-a23b-ece0c859958f,1.1.7,71.43,75.25,Bronze,QTL Programme at MRC HGU,71.43,351cc017-caff-4303-8a48-1aa1b90fce2b,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,60.32,227fe0ea-d76e-4c14-a33e-ca255380937d,1.1.7,69.05,74.06,Bronze,Children's Cancer and Leukaemia Group (CCLG) Tissue Bank,69.84,c232fa07-5d28-4bdc-b540-1ad8d933c5f9,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,60.32,22974866-44c7-4176-9c51-6b57a1dda39d,1.1.7,69.05,74.06,Bronze,University of Liverpool - GCP Laboratory Facility,69.84,029b7f0f-911e-46ce-837f-031959f067da,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,19.05,22aecb42-9ea3-4d60-b392-d3cdd0a806f8,1.1.7,21.43,39.78,Not Rated,CDE Encounters,38.89,3598723f-62fb-4377-9a8b-b264ced1aabd,41.86,ALLIANCE > BARTS HEALTH,41.27
Gold,100.0,22e67d6b-3c86-46bc-8472-97ebe70773fa,1.1.7,95.24,85.99,Silver,COG-UK Viral Genome Sequences,87.3,1fe02b65-7b77-43bf-93c8-4f0743fee672,23.26,ALLIANCE > COVID-19 GENOMICS UK,25.4
Not Rated,22.22,23330792-fe18-4331-a101-b246657a03ae,1.1.7,26.19,47.98,Not Rated,National Joint Registry - Revision Knee Replacement dataset,45.23,6664317b-39b9-4133-b6c7-ec4bddf78c76,30.23,ALLIANCE > HQIP,31.75
Not Rated,22.22,237e724d-03b2-478c-a92d-85a1baa6ae53,1.1.7,26.19,45.66,Not Rated,Falls and Fragility Fracture Audit Programme Fracture Liaison Service Database clinical dataset,42.86,d94a604c-5733-4f07-93bb-e77b6ea2313f,34.88,ALLIANCE > HQIP,36.51
Silver,100.0,239e8253-a997-4676-8940-16b74a004365,1.1.7,95.24,82.5,Silver,GENOMICS ENGLAND 100K RARE DISEASE & COMMON,82.54,3f2b37f1-e8f7-42e5-83c4-fc9e1c58725d,30.23,GENOMICS ENGLAND,34.92
Silver,71.43,24b82645-1854-438a-97b2-911bba469d3d,1.1.7,80.95,84.66,Silver,Idiopathic Pulmonary Fibrosis (IPF) Genome-wide Association Study,79.37,b850e56c-5c5b-413e-b829-743772053978,11.63,HUB > BREATHE,12.7
Bronze,60.32,24f2374a-e804-434e-a805-e29b332b0693,1.1.7,69.05,72.89,Bronze,SWIFT-RTB,69.05,d387ed7c-14fa-49e2-8ced-df0f9372eb88,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Bronze,57.14,2542abf8-e50b-4962-9fa1-6dba1b7e8439,1.1.7,66.67,75.19,Bronze,mHealth for pneumonia prevention,69.05,fc66381e-cc46-4bca-85fc-fc2ee09cc5dd,16.28,HUB > BREATHE,19.05
Silver,90.48,2550f814-0849-4d19-b83e-edef46b157fb,1.1.7,83.33,77.71,Silver,Intensive Care National Audit and Research Centre - Covid19,79.37,add6226b-0f21-439a-84a6-51dc26cdc425,27.91,ALLIANCE > SAIL,31.75
Silver,87.3,262c28eb-151e-4ab2-a813-81841f5292eb,1.1.7,78.57,73.0,Bronze,Patient postcode linked deprivation measures for CPRD Aurum,78.57,bd85a09c-fe4a-41b8-81d2-77feadcd1a0a,32.56,ALLIANCE > CPRD,30.16
Not Rated,77.78,263ad0a8-ae90-4c1d-85d6-c3d2470eb2b7,1.1.7,64.29,56.57,Not Rated,Mental Health Minimum Dataset v4 (Non-Sensitive) Episodes,61.11,2964d1b0-2630-468a-82c1-00f5ac901b3d,51.16,ALLIANCE > NHS DIGITAL,55.56
Not Rated,77.78,263f28a4-9835-4856-b1c3-0a0d4085f207,1.1.7,64.29,56.57,Not Rated,Mental Health Minimum Dataset v2.6 (Sensitive),61.11,dc37fcd6-1e68-46e5-b73d-4896e069746a,51.16,ALLIANCE > NHS DIGITAL,55.56
Bronze,65.08,263f4ce3-7ccf-45c3-9d41-c1f5ed14cc81,1.1.7,73.81,76.44,Silver,Arden Tissue Bank,72.22,62fdfd1c-f195-49cc-b3a1-7d9fd2cc8e1b,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Gold,100.0,265cb00e-1731-4370-b748-203d8bd6c416,1.1.7,95.24,88.32,Gold,Welsh Cancer Intelligence and Surveillance Unit (WCISU),89.69,368ad790-3ad8-4f93-9a7c-0bfb64dc6015,18.6,ALLIANCE > SAIL,20.63
Silver,82.54,26b03931-18ce-4a83-99de-1fca258518f3,1.1.7,76.19,78.8,Silver,Child Health Systems Programme - 27-30Months Review,81.75,d2d57b7f-95d8-425f-b2fd-cc9aff05e659,18.6,ALLIANCE > PUBLIC HEALTH SCOTLAND,19.05
Bronze,66.67,270b55a8-a9ee-44ee-8db6-eb214e721eea,1.1.7,76.19,76.47,Silver,Scottish Human Papillomavirus Archive,72.22,4883530f-1c8d-49aa-886e-ea3b958772ea,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Silver,85.71,273e091c-d0b3-4529-9cd2-4bc1a1b6195a,1.1.7,78.57,75.33,Bronze,"Deeply phenotyped sepsis patients within hospital: onset, treatments & outcomes",79.36,38ff49e2-dffa-4103-87a8-386f9f424d22,27.91,HUB > PIONEER,26.98
Not Rated,22.22,278c3fb2-6b1e-46db-a529-9fc7ddaf4461,1.1.7,26.19,45.66,Not Rated,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (clinical),42.86,33b36393-3760-40d8-bb98-61806fea5398,34.88,ALLIANCE > HQIP,36.51
Bronze,79.37,28bb6308-013f-47d3-8c4b-74720ad3901d,1.1.7,71.43,72.93,Bronze,Labour Force Survey (Longitudinal),75.4,4ac15572-fe9a-46d3-860d-a46b616181f7,25.58,NCS > OFFICE FOR NATIONAL STATISTICS,28.57
Silver,88.89,2918676c-74b0-4a4e-8814-697e9aa6a81c,1.1.7,80.95,73.03,Bronze,National Radiotherapy Dataset (RTDS) for CPRD GOLD,78.57,56a66de8-3470-4a36-ac71-4d5471e72654,34.88,ALLIANCE > CPRD,31.75
Not Rated,15.87,29de7178-dcf3-4859-bd96-ca6d944db5f8,1.1.7,19.05,37.43,Not Rated,DENDRITE Dataset,36.51,31920b14-d114-410f-8255-522e6451c44e,44.19,ALLIANCE > BARTS HEALTH,42.86
Not Rated,77.78,2a725f9d-c4a9-4c89-aa37-b3c25cc83389,1.1.7,64.29,56.57,Not Rated,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Records,61.11,7c2b435c-5442-4a05-9b8d-08024ec57c30,51.16,ALLIANCE > NHS DIGITAL,55.56
Not Rated,17.46,2ab363bf-3013-475b-8254-bd7740f70edb,1.1.7,21.43,42.11,Not Rated,Renal Register – ISD National dataset,40.48,32edd77d-533c-423f-b045-937507f8505d,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Silver,98.41,2b09ea87-5b22-4049-b7dd-de0889699115,1.1.7,92.86,84.8,Silver,Millennium Cohort Study,85.72,a380bd6b-009f-4b78-b638-ba9ee62be2eb,23.26,ALLIANCE > SAIL,26.98
Silver,85.71,2b40a784-79ea-4403-a4bd-0950a7a36a6c,1.1.7,78.57,73.0,Bronze,Leeds-IQVIA Collaboration,76.98,00b897c7-d50d-486a-af1b-bd94821b58f7,32.56,HUB > DATA-CAN,31.75
Bronze,63.49,2bd45ffb-b22f-4f02-968b-f5ab8f9d6342,1.1.7,71.43,72.93,Bronze,UCL Infection DNA Bank,69.05,3e5fb54a-84ec-4888-9a72-4093c6e90dbc,25.58,ALLIANCE > TISSUE DIRECTORY,25.4
Not Rated,22.22,2c0e04bc-2f16-4903-90dc-c9d57ab40efb,1.1.7,26.19,47.98,Not Rated,National Joint Registry - Revision Ankle Replacement dataset,45.23,b4f076d2-c9a3-49ba-84f4-94148dc8511a,30.23,ALLIANCE > HQIP,31.75
Bronze,60.32,2c3e75c3-141a-4d29-b7f0-0dbe14fb18fd,1.1.7,69.05,74.06,Bronze,MDSBio,69.84,13c71637-144e-4742-8aea-aefb778a360e,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,22.22,2c53d1f7-4540-4c57-8e93-8115b8abc6a9,1.1.7,26.19,47.98,Not Rated,National Diabetes Inpatient Audit Hospital Characteristics Survey dataset,45.23,a9098b51-f8ec-432e-a52f-f4c1f2c1e4f6,30.23,ALLIANCE > HQIP,31.75
Bronze,88.89,2d25b733-d95a-485b-9499-907a48b51919,1.1.7,80.95,71.87,Bronze,Mental Health Dataset (MHDS) for CPRD GOLD,74.61,d5c0cc93-3347-46f0-b8dd-f44e82718e38,37.21,ALLIANCE > CPRD,39.68
Silver,100.0,2d4b933d-1c8b-4fde-860e-c324454d28f9,1.1.7,95.24,83.66,Silver,GENOMICS ENGLAND 100K NHSD LINKED DATA,84.92,14c31b39-f189-4417-bd38-635268495593,27.91,GENOMICS ENGLAND,30.16
Not Rated,47.62,2d6e8e68-2fc9-4b9c-a517-c5c5677af225,1.1.7,57.14,66.94,Bronze,IBD NIHR BioResource: NHS Trust data,61.91,ae1898da-7fe5-4fe0-b10d-9f06cdec1735,23.26,HUB > GUT REACTION,23.81
Not Rated,22.22,2dbd2e38-a4bb-4f8c-b401-ebec10f0d89e,1.1.7,26.19,45.66,Not Rated,Falls and Fragility Fracture Audit Programme National Hip Database Facilities Survey 2019,42.86,025c9e8a-938b-4886-9e03-fcad90fe7157,34.88,ALLIANCE > HQIP,36.51
Not Rated,52.38,2dc79612-0e0d-4336-aaa1-6abd90d28589,1.1.7,59.52,69.3,Bronze,"4 Country ChrOnic: estimating respiratory disease burden in adults, South India",65.08,2f1244b8-7cbf-4fa3-8534-433efd769d48,20.93,HUB > BREATHE,22.22
Gold,100.0,2ef8bfd7-3edb-49e0-a1eb-edc181c03e1d,1.1.7,95.24,87.16,Gold,Patient Episode Dataset for Wales,88.89,4c33a5d2-164c-41d7-9797-dc2b008cc852,20.93,ALLIANCE > SAIL,22.22
Bronze,60.32,2fee4aae-94c4-40b2-9e35-4f9558a5b223,1.1.7,66.67,70.55,Bronze,Cancer Patient Experience Survey (CPES) for CPRD Aurum,68.25,fded6e24-8fef-47a4-a65e-9455bed043d3,25.58,ALLIANCE > CPRD,23.81
Not Rated,22.22,304430ff-0aff-4d36-91e5-94be251a409a,1.1.7,26.19,47.98,Not Rated,National Audit of Dementia Round 4 - casenote audit,45.23,587a94e6-48a4-4e5e-8230-4018897bc7c7,30.23,ALLIANCE > HQIP,31.75
Bronze,60.32,30a0ee0e-d9f9-4341-b00c-2fab8f122b5f,1.1.7,69.05,74.06,Bronze,Watch and Wait Trial,69.84,e46dccbf-484d-45d2-a42a-4d308b87c113,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Silver,87.3,3141f405-9653-4189-9a1f-443a463d4b1b,1.1.7,78.57,74.17,Bronze,Systemic Anti-Cancer Therapy Dataset [SACT],76.98,6c4ed998-0f05-415c-a3e4-42430bb62d24,30.23,ALLIANCE > SAIL,33.33
Silver,85.71,32bff357-1c24-43d5-8741-261f5a764802,1.1.7,76.19,70.66,Bronze,Practice postcode linked deprivation measures for CPRD Aurum,76.98,9f689ef4-26c6-4f85-80ff-5116974f315a,34.88,ALLIANCE > CPRD,31.75
Gold,100.0,333d92ca-3a32-41bd-8b16-96aee2dc85b1,1.1.7,95.24,85.99,Silver,Wales Asthma Observatory,86.51,8604bcdc-235a-4c70-b29b-1617396815e6,23.26,HUB > BREATHE,26.98
Bronze,60.32,33e4b8c6-23cc-4c5f-a7a5-8380035b6601,1.1.7,69.05,72.89,Bronze,TRICON8B,69.05,ff875c08-58e6-4e33-8ffe-6f51c8364333,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Not Rated,17.46,33e96a6f-8791-48c7-a440-889dba594c36,1.1.7,21.43,42.11,Not Rated,"Deaths – CHI, Community Health Index",40.48,faf2fc49-d09f-4ea2-a2cb-b1d30fffa406,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Bronze,80.95,34b788e3-37c9-4cea-ac12-f210c499eafd,1.1.7,73.81,70.62,Bronze,Admissions & Discharges,74.6,1d5b9205-dae4-4b0e-a3d3-04707875edf8,32.56,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,31.75
Silver,85.71,34d2310f-c5f2-42c4-be1a-31c1ad579013,1.1.7,78.57,73.0,Bronze,Hospital Episode Statistics Critical Care,76.19,80564a6b-1458-41de-a131-772eb93c0509,32.56,ALLIANCE > NHS DIGITAL,33.33
Silver,85.71,34f9be53-2445-439b-8ca4-f151359d7e46,1.1.7,78.57,71.84,Bronze,National Cancer TRE,76.19,b5439bc5-8141-4a13-a024-a6db2003b40e,34.88,HUB > DATA-CAN,33.33
Bronze,63.49,359006d7-1c6c-43c2-8905-09b016398ae1,1.1.7,71.43,75.25,Bronze,BRAIN UK,71.43,1c455ad3-af51-4b93-aff4-c5d3dacfa9f4,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,77.78,36047c5f-7d57-4d25-a114-2bcc6c11708f,1.1.7,64.29,56.57,Not Rated,Mental Health Minimum Dataset v3_3.5 (Sensitive),61.11,c123f74c-0731-428e-b31b-eee2723df54d,51.16,ALLIANCE > NHS DIGITAL,55.56
Silver,85.71,36d3480e-38ae-470c-ab6f-b704ee2645ec,1.1.7,76.19,70.66,Bronze,Practice postcode linked deprivation measures for CPRD GOLD,76.98,3326d554-ca11-4dc6-aff0-c5b314442d27,34.88,ALLIANCE > CPRD,31.75
Silver,88.89,372083bc-3243-4fce-989d-914e677a12cd,1.1.7,80.95,73.03,Bronze,National Radiotherapy Dataset (RTDS) for CPRD Aurum,78.57,9c535c8d-ebac-4212-b602-fc2489df2c92,34.88,ALLIANCE > CPRD,31.75
Not Rated,17.46,3728b674-68a2-4710-9f8e-b0fc3f2add10,1.1.7,21.43,42.11,Not Rated,NHS Tayside and Fife Accident & Emergency Dataset (ISD/National),40.48,750063ea-6bfd-4492-9748-2a18080cf6ea,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Bronze,63.49,37687806-bab2-4de8-87a7-844a0061e7f8,1.1.7,71.43,75.25,Bronze,Bristol Dental School Saliva Bank,71.43,8d77f0ad-f376-4d61-a97d-5e996c2bbe72,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,46.03,37eb2884-d7df-489f-a3ad-f02f1e510475,1.1.7,52.38,66.89,Bronze,Exploring psychological issues of primary care teams in Malaysia amidst COVID-19,62.7,64f78a5f-268f-4951-9c91-f7e7130baffa,18.6,HUB > BREATHE,20.63
Bronze,63.49,381413fe-8808-47f8-b8df-e65baa543ae4,1.1.7,71.43,75.25,Bronze,UK MND Collections,71.43,89e2d798-c488-4eaf-a50f-a93616093304,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Silver,96.83,38194ca7-57f5-40ff-b463-900e306cd40f,1.1.7,92.86,82.47,Silver,North West London Pathology (NWL PATH),81.75,2c5f3ef6-53f8-42e6-a077-8718261df026,27.91,HUB > DISCOVER NOW,33.33
Bronze,60.32,38254214-35f1-4564-b7bb-aab331732dab,1.1.7,69.05,72.89,Bronze,NIHR Nottingham Digestive Diseases Collection,68.25,f20bf814-ee80-4e67-ab00-afff884ddbb4,23.26,ALLIANCE > TISSUE DIRECTORY,23.81
Gold,100.0,38468759-3351-4722-9eeb-4c6dc9fa44ce,1.1.7,95.24,88.32,Gold,Congenital Anomaly Register and Information Service,89.69,6fe7e004-eb51-4c7b-9905-1ec9a4827dca,18.6,ALLIANCE > SAIL,20.63
Silver,85.71,391ab58c-3412-4fa0-96f6-fdd5ae380b86,1.1.7,78.57,75.33,Bronze,Clinical response thresholds (acuity) in acutely unwell patients: onset-outcome,79.36,a9018475-452b-4864-bbc3-80eda2067820,27.91,HUB > PIONEER,26.98
Not Rated,77.78,3935e2fd-0c30-4f56-8388-45a02e0499b4,1.1.7,64.29,58.89,Not Rated,Bridge file: Hospital Episode Statistics to Diagnostic Imaging Dataset,64.28,2f73575d-23c8-4bb8-87db-115cde076127,46.51,ALLIANCE > NHS DIGITAL,49.21
Not Rated,22.22,395262e7-9846-4d9d-a288-8b0ebea782b9,1.1.7,26.19,46.81,Not Rated,National Cardiac Audit Programme - Cardiac Rhythm Management (CRM),43.65,3cc81e6c-0c17-4ccd-8202-a9aceb82c989,32.56,ALLIANCE > HQIP,34.92
Not Rated,22.22,3a51b861-026d-45ed-abe6-30d9cc07b516,1.1.7,26.19,47.98,Not Rated,Epilepsy 12 - clinical audit,45.23,1fcaf429-8762-454c-b999-c5fdd757b880,30.23,ALLIANCE > HQIP,31.75
Not Rated,38.1,3a56c317-bf1b-448d-89ab-3421eae3aa18,1.1.7,42.86,57.48,Not Rated,Death register,56.35,722056a5-5fc6-4ad2-8efe-62a80dd6389b,27.91,UK Biobank,25.4
Not Rated,22.22,3a9ab245-5fcc-49a0-ae58-12ebab9b0053,1.1.7,26.19,45.66,Not Rated,National Paediatric Diabetes Audit - Spotlight survey of workforce in Paediatric Diabetes Units,42.86,fe8f8e2c-2f77-464d-9d45-a601cb2f8bf9,34.88,ALLIANCE > HQIP,36.51
Bronze,55.56,3aa01779-831e-478f-b4e3-7c111d642b18,1.1.7,64.29,74.0,Bronze,COVID-19 Detection from Chest X-Rays using Deep Learning,68.25,57526718-0a9a-42ad-8b7a-582d9ef96d13,16.28,HUB > BREATHE,19.05
Gold,100.0,3ab70331-aa54-4f0d-aa95-ea2b95bed9d5,1.1.7,95.24,87.16,Gold,Annual District Birth Extract,87.3,12a77014-4a77-4eb1-8b26-f49689352d1b,20.93,ALLIANCE > SAIL,25.4
Gold,100.0,3abe6b38-e479-4eb3-87d6-ef4803ff88f9,1.1.7,95.24,87.16,Gold,Emergency Department Data Set,87.3,75c4dcb8-33bf-43f4-b2bb-db51b6621b2c,20.93,ALLIANCE > SAIL,25.4
Silver,92.06,3b0a3b33-dbd5-4cb0-b863-0e1fd80c9a1e,1.1.7,88.1,82.42,Silver,IBD NIHR BioResource: Consent records,82.54,44ca2cf8-679e-447c-a9eb-55b32159679a,23.26,HUB > GUT REACTION,26.98
Not Rated,15.87,3b752633-8274-4418-b15b-4502bab03935,1.1.7,19.05,38.59,Not Rated,CDE Surginet Documentation,37.3,4c4bc482-16f5-462f-8daf-51ec6492074d,41.86,ALLIANCE > BARTS HEALTH,41.27
Bronze,57.14,3bb25cba-b4dc-47f1-ab5e-b63f89500612,1.1.7,64.29,70.52,Bronze,IBD NIHR BioResource: SNP imputation data,66.66,7dee2bd6-733a-4b2e-a942-7f9eaf8ebbc2,23.26,HUB > GUT REACTION,23.81
Bronze,61.9,3c23941a-42a7-4940-b32f-aea743c0dc2a,1.1.7,71.43,74.09,Bronze,Tissue Solutions Ltd,69.84,bbcdc352-e0f7-4672-93a7-134bcf5001b1,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Bronze,63.49,3ce4870c-5062-4d01-8801-2cf505b979b7,1.1.7,71.43,75.25,Bronze,TwinsUK,71.43,19b4cd38-3828-4bb1-a980-4f7420658965,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,79.37,3d13bc38-3f7f-4807-8847-2a10d6402dd3,1.1.7,73.81,71.79,Bronze,Cancer Network Information System - CNIS / CANISC,72.22,da91f0eb-1761-485b-8b7f-9121b6a1d004,30.23,ALLIANCE > SAIL,34.92
Silver,96.83,3d51dc99-c44f-44ff-bdab-da205c5e394e,1.1.7,92.86,83.64,Silver,North West London Outpatient Care Data (NWL OP),84.13,9f1df859-f1d0-4f1e-959e-affd05138a25,25.58,HUB > DISCOVER NOW,28.57
Not Rated,44.44,3d8c1942-ba41-44aa-8ca8-9051a878ec44,1.1.7,50.0,61.05,Not Rated,Blended learning for primary care physicians on COPD in Bangladesh,57.94,3907a55f-104b-4533-ba21-69bd5f08ce8f,27.91,HUB > BREATHE,28.57
Bronze,60.32,3db58c78-fc8b-49b2-a847-b43fd0184500,1.1.7,69.05,74.06,Bronze,Ethical Tissue - University of Bradford,69.84,fdf9ac68-fc89-4adf-9a73-3a94a9974aef,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,46.03,3e13c6f0-2760-4ece-b047-77d750d9cdbd,1.1.7,35.71,45.76,Not Rated,Prescribing,50.0,6d044471-62d2-4190-b315-503f77d33ef2,44.19,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,46.03
Not Rated,22.22,3e89692b-7aa2-49d6-b802-82921bd7e006,1.1.7,26.19,46.81,Not Rated,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (patient experience survey),44.45,d94eb31c-04c4-41b6-ad38-45f6aef30132,32.56,ALLIANCE > HQIP,33.33
Bronze,60.32,3f00330d-1f45-4cab-86c2-e91b7c1a59e9,1.1.7,69.05,74.06,Bronze,Multiple Sclerosis and Parkinson's Tissue Bank,69.84,4684d391-a6a7-44f7-bf4b-62b6b693f9fa,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,49.21,3f1d93ae-792e-4f0c-8cb7-40413b81e132,1.1.7,59.52,68.13,Bronze,NIHR BioResource: NHS Trust data,62.7,3731006a-ee7c-4d15-bc07-4eeb29a3d031,23.26,ALLIANCE > NIHR BIORESOURCE,23.81
Not Rated,22.22,3f299029-3126-4ce0-893c-4a759cbe90b1,1.1.7,26.19,46.81,Not Rated,National Emergency Laparotomy Audit - Patient Audit Dataset,43.65,25b93812-191f-49bb-bbd0-782fb85b2bd2,32.56,ALLIANCE > HQIP,34.92
Bronze,84.13,3fb045f9-6295-4406-b782-3c4133c278a7,1.1.7,76.19,70.66,Bronze,Covid-19 UK Non-hospital Antigen Testing Results,74.6,f06ec631-77d0-4b12-a21f-f11e7af49ba5,34.88,ALLIANCE > NHS DIGITAL,34.92
Bronze,87.3,3fb06d01-cde5-4e68-b438-cfa0b0f8de9a,1.1.7,78.57,74.17,Bronze,2011 Census variables (and variable breakdowns),75.39,a05aef07-c3fa-4331-905a-6b6f58eac3d5,30.23,ALLIANCE > PUBLIC HEALTH SCOTLAND,36.51
Silver,85.71,3fbef1ac-fa6d-4c72-836d-3a8d8a0f7b08,1.1.7,78.57,74.17,Bronze,Barts Health NHS Trust COVID-19 EHR Extracted Dataset,77.78,,30.23,ALLIANCE > BARTS HEALTH,30.16
Silver,85.71,3fc555e1-3e36-46dc-bef1-2d94d560bcb2,1.1.7,78.57,74.17,Bronze,The impact of ethnicity and multi-morbidity on C19 hospitalised outcomes,76.98,cfa1ef13-8ae0-4827-8a0f-9d2df5244725,30.23,HUB > PIONEER,31.75
Gold,100.0,3fceb952-0b21-40f4-bd69-fa5cd7ad7df9,1.1.7,95.24,88.32,Gold,Cafcass Wales,89.69,29a714e1-5289-4362-be24-2848c954344e,18.6,ALLIANCE > SAIL,20.63
Not Rated,14.29,40573895-497b-4d47-90e1-6aafe70b93f6,1.1.7,16.67,38.57,Not Rated,Endobase,37.3,e830b2a5-14d6-4643-a206-619bf5372dc8,39.53,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.68
Bronze,77.78,41a667eb-1c84-4665-b0d4-d26405d277c5,1.1.7,71.43,70.6,Bronze,Domiciliary Social Care Worker [DSCW],73.02,0e38bbf4-c788-4a1a-9af8-a24821250154,30.23,ALLIANCE > SAIL,31.75
Silver,88.89,41ce265a-c252-45c4-9b80-d764b0737f38,1.1.7,80.95,74.19,Bronze,Quality of Life of Colorectal Cancer Survivors: Patient Reported Outcomes (Aurum,77.78,bfb90d2b-746d-44a6-a896-4979d73d9276,32.56,ALLIANCE > CPRD,33.33
Bronze,85.71,41f84b0f-0621-4e21-937b-cc05c183166b,1.1.7,78.57,71.84,Bronze,Hospital Episode Statistics Outpatients,75.39,d4362d41-0838-4f41-bba3-c3268312c444,34.88,ALLIANCE > NHS DIGITAL,34.92
Not Rated,74.6,4262e057-6978-4e4c-a05d-c4f328422090,1.1.7,61.9,57.7,Not Rated,Mental Health and Learning Disabilities Data Set,64.28,e9b43936-e700-40c9-8b32-57ed44583f3d,46.51,ALLIANCE > NHS DIGITAL,46.03
Not Rated,22.22,4271bc64-b139-40b0-98de-5f2e94e2d026,1.1.7,26.19,47.98,Not Rated,National Neonatal Audit Programme - 2 year outcomes audit,45.23,3bb02d77-9678-4e6e-832d-c2ed3ede412c,30.23,ALLIANCE > HQIP,31.75
Silver,100.0,42ac7c27-a37b-4081-8a33-51ac077e6a4e,1.1.7,95.24,83.66,Silver,Cystic Fibrosis Patient Microbiology Cultures,81.75,9c1727f6-2032-413f-bf60-470769b2616e,27.91,ALLIANCE > CYSTIC FIBROSIS TRUST,36.51
Not Rated,22.22,430331ef-fa66-485b-b090-e4e83def9136,1.1.7,26.19,45.66,Not Rated,Falls and Fragility Fracture Audit Programme National Audit of Inpatient Falls clinical dataset,42.86,3c19e2c9-96d5-45f3-9c55-fc3cec762cd7,34.88,ALLIANCE > HQIP,36.51
Silver,90.48,4353b5fa-b3aa-4786-9e7f-4fb2273f5d3e,1.1.7,83.33,73.06,Bronze,Systemic Anti-Cancer Treatment (SACT) data for CPRD Aurum,76.98,f8af632e-442d-4931-a370-b7fa2fa4b896,37.21,ALLIANCE > CPRD,36.51
Not Rated,44.44,444c1f10-cb6b-4aee-a3cd-93876bc451b6,1.1.7,50.0,61.05,Not Rated,Childhood Pneumonia Governance in Bangladesh,57.94,5df03d24-ad95-4d64-96df-0684a4f26e58,27.91,HUB > BREATHE,28.57
Gold,98.41,45499ef9-daca-4a88-8493-c3c1a92960d0,1.1.7,92.86,87.13,Gold,Welsh Ambulance Services NHS Trust,88.89,d415a5c5-8432-4a81-937f-12135ade6de7,18.6,ALLIANCE > SAIL,20.63
Not Rated,77.78,46493a09-b3bb-4c0e-b944-82665ee21508,1.1.7,64.29,56.57,Not Rated,Mental Health Minimum Dataset v4 (Sensitive) Events,61.11,9c31a2bd-ff3a-4379-a4b8-0b90527a4c38,51.16,ALLIANCE > NHS DIGITAL,55.56
Not Rated,22.22,4678a81d-dfb6-478a-a373-d5510866b3d0,1.1.7,26.19,47.98,Not Rated,National Vascular Registry - Organisational Audit dataset,45.23,3c661240-e4d2-456c-a809-133c23f9c469,30.23,ALLIANCE > HQIP,31.75
Gold,100.0,46e30817-b19e-40f2-9b06-9611b2985148,1.1.7,95.24,88.32,Gold,Maternity Indicators Dataset,89.69,a0c27454-8cbe-418f-bdae-a85d5e92e9d4,18.6,ALLIANCE > SAIL,20.63
Not Rated,22.22,46e4c3ba-dae2-453d-832a-88ea603110f1,1.1.7,26.19,45.66,Not Rated,National Cardiac Audit Programme - National Congenital Heart Disease Audit (NCHDA),42.86,2b640175-725a-465f-9aec-6794e6d27791,34.88,ALLIANCE > HQIP,36.51
Not Rated,22.22,47bec08b-57b7-450e-9be7-af19bab99b58,1.1.7,26.19,47.98,Not Rated,National Vascular Registry Audit - Lower Limb Bypass clinical dataset,45.23,d357be1e-27fe-4b2f-9174-3a2a03ecc12b,30.23,ALLIANCE > HQIP,31.75
Bronze,60.32,47d22aea-cbe9-47d4-8f65-45861d9c5f6f,1.1.7,69.05,74.06,Bronze,Tayside Biorepository,69.84,6ac9b356-00f1-49da-825a-6eb04d18e49d,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,53.97,47e9fa0a-d74f-43bc-ae63-0eb33f354f01,1.1.7,61.9,71.65,Bronze,Theory of Planned Behaviour Intervention: respiratory disease in South India,66.67,7d23e729-72b0-4dd1-820d-07697b49acd0,18.6,HUB > BREATHE,20.63
Bronze,63.49,47f57de8-aa71-4df1-af4a-a81e37d4ae8c,1.1.7,71.43,72.93,Bronze,"St Thomas' Hospitals Plasma, serum & DNA Bio bank from patients with antiphospholipid antibodies",69.84,425f4534-51c4-4f75-8ca0-d7c731dbd903,25.58,ALLIANCE > TISSUE DIRECTORY,23.81
Not Rated,34.92,480ccd8a-309e-417a-ac23-5b2d9cd281b1,1.1.7,38.1,55.09,Not Rated,Genotype,53.97,93a7352f-fce4-42c9-9a8c-efc7fe23eda0,27.91,UK Biobank,26.98
Silver,96.83,48182af6-2ccd-44b2-92d5-69cc140e7d67,1.1.7,92.86,83.64,Silver,North West London Primary Care Prescriptions Data (NWL PCP),84.13,0fb33df6-ab36-4170-9fad-1eaf35a3a812,25.58,HUB > DISCOVER NOW,28.57
Silver,90.48,484bff65-c47e-47ce-9eb5-5d381f961160,1.1.7,83.33,73.06,Bronze,Cancer registration data for CPRD Aurum,76.98,3f3df3be-05a8-42b2-89d9-f731deb7ea66,37.21,ALLIANCE > CPRD,36.51
Bronze,85.71,4a0668a8-391e-4cfa-aa99-0ab9ba9321ea,1.1.7,78.57,69.52,Bronze,Civil Registration - Deaths,70.63,050163dc-1728-4ac5-a7d9-4dd3ca0ca12a,39.53,ALLIANCE > NHS DIGITAL,44.44
Gold,98.41,4b6d3344-e73a-4f46-8e9d-fabb85827772,1.1.7,92.86,87.13,Gold,Daily Situation Report Data,88.89,c74a9b9e-1fea-4aac-99fd-54e30668e085,18.6,ALLIANCE > SAIL,20.63
Not Rated,22.22,4b71fca4-8b2c-4e37-8996-b64a9c1450f0,1.1.7,26.19,45.66,Not Rated,National Paediatric Diabetes Audit - Spotlight survey of diabetes-related technologies,42.86,eecbdd8d-92a0-4dfd-a216-1cf7f1f8c98f,34.88,ALLIANCE > HQIP,36.51
Bronze,60.32,4cde083a-bf5a-4f57-97c6-38632e10050d,1.1.7,69.05,74.06,Bronze,Obesity Research Biobank Syndicate (ORBiS),69.84,264a1987-a8cb-4a83-81e0-70b4c3893b7d,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Silver,98.41,4d0f0156-8109-4100-868c-06a17495a024,1.1.7,92.86,78.99,Silver,CPRD GOLD,80.95,a29feafa-7bdd-44e9-b977-c9d26425e67f,34.88,ALLIANCE > CPRD,36.51
Bronze,60.32,4dd3f23c-44be-4126-aac5-ba655d07855c,1.1.7,69.05,74.06,Bronze,POUT-T,69.84,c6e0e70e-7f23-4a44-a2cf-1d7d87be7808,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,50.79,505318b6-609c-4baf-9dea-2e3532f936f8,1.1.7,61.9,69.32,Bronze,COPDMAP Consortium,63.49,bcbc41cb-99f7-482e-ba3d-561164abbd4e,23.26,HUB > BREATHE,23.81
Not Rated,22.22,50631db6-126e-4b3a-8035-444b66ba4afa,1.1.7,26.19,46.81,Not Rated,National Audit of Psychosis - Audit on Early Intervention in Psychosis services -  patient experience survey,44.45,c3e63860-bd61-4154-ab5f-ca927fb029c4,32.56,ALLIANCE > HQIP,33.33
Silver,88.89,50925199-a35d-4327-87cd-7761d713a72b,1.1.7,83.33,74.22,Bronze,HES Outpatient data for CPRD Aurum,76.98,8d3f3e58-be79-4450-b2e3-f5ab8a25fb0e,34.88,ALLIANCE > CPRD,34.92
Silver,92.06,5158e513-2f13-40f3-8f8a-b96a3e179fc9,1.1.7,85.71,76.57,Silver,CPRD Cardiovascular Disease Synthetic Dataset,79.37,780c0a71-0264-4843-939d-1336eee60d40,32.56,ALLIANCE > CPRD,33.33
Not Rated,15.87,5271131b-ba5b-452d-b230-077094a031c2,1.1.7,19.05,38.59,Not Rated,ARIA Dataset,37.3,621dd611-adcf-4434-b538-eecdbe5f72cf,41.86,ALLIANCE > BARTS HEALTH,41.27
Bronze,85.71,52a467b0-5401-4818-9c16-2e41d68704c1,1.1.7,78.57,73.0,Bronze,NIHR BioResource: SNP chip data,73.8,c388676c-a5e5-419c-967c-239c1f0c3c5c,32.56,ALLIANCE > NIHR BIORESOURCE,38.1
Bronze,88.89,52c784f6-99c6-4407-b660-abaa1682c955,1.1.7,80.95,71.87,Bronze,Mental Health Dataset (MHDS) for CPRD Aurum,74.61,48627b2d-f247-4921-9ee1-6c37adfff10d,37.21,ALLIANCE > CPRD,39.68
Silver,96.83,535a0983-6618-4211-a939-ae2edfe26f9a,1.1.7,92.86,82.47,Silver,North West London Adult Social Care Data (NWL ASC),81.75,de9cf0f5-b26a-4363-9df8-3628a4aa6b6e,27.91,HUB > DISCOVER NOW,33.33
Not Rated,22.22,535fbfd4-34f0-436d-8de2-e708fd0fa103,1.1.7,26.19,47.98,Not Rated,National Audit of Care at the End of Life - organisational level audit,45.23,a290592c-a6f5-4874-b283-1d33e923c487,30.23,ALLIANCE > HQIP,31.75
Silver,82.54,53b7c446-667b-409e-920e-67cb516de3ae,1.1.7,73.81,72.95,Bronze,Ventilatory strategies and outcomes for patients with COVID: a dataset in OMOP,77.78,cacba424-6c2c-4b57-8f5b-64e92a78370a,27.91,HUB > PIONEER,26.98
Bronze,82.54,542baa13-5d19-424e-b747-b2e57922df01,1.1.7,76.19,71.81,Bronze,Business Impact of COVID-19 Survey (BICS),73.02,8e739a01-bcfa-4b75-b7f8-e694ee185f8d,32.56,NCS > OFFICE FOR NATIONAL STATISTICS,36.51
Bronze,60.32,54a7dd45-d6c7-4b4d-801d-2becd2b694f1,1.1.7,69.05,74.06,Bronze,Epilepsy Society Brain and Tissue Bank,69.84,f13258c3-f85a-4772-b42e-da8a84c5064a,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,22.22,5536b00a-fb31-4e91-9bd8-e7f774974846,1.1.7,26.19,47.98,Not Rated,National Vascular Registry - Lower Limb Angioplasty clinical dataset,45.23,c8b6c319-239b-4792-9898-644a63d07ab5,30.23,ALLIANCE > HQIP,31.75
Gold,100.0,553a0fcb-6bed-493c-a185-fa97dc5f370d,1.1.7,95.24,85.99,Silver,National Community Child Health Database (NCCHD),88.09,20fe153c-a5e5-4991-900e-8fa9988e771a,23.26,ALLIANCE > SAIL,23.81
Bronze,53.97,561b8a79-6bac-4ffc-91f4-0bbec4e90968,1.1.7,61.9,72.81,Bronze,Care-seeking practices for childhood pneumonia in non/tribal areas of Pune India,67.46,4346676d-6108-47de-b579-6cef74c6acef,16.28,HUB > BREATHE,19.05
Bronze,60.32,567b23fe-abf2-4e2e-88f7-505dfeaa3cde,1.1.7,69.05,74.06,Bronze,LBIH Biobank,69.84,c0318a31-a32c-4d3a-9591-dfe9352bf2b9,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Silver,80.95,56c3aabb-cb99-4da9-a6ed-3212c02e6f20,1.1.7,73.81,74.12,Bronze,"Diabetic Eye Screening: the Birmingham, Solihull and Black Country Data Set",77.78,36886b21-12ff-45e7-82bc-fb5308c12450,25.58,HUB > INSIGHT,25.4
Bronze,60.32,56f3e791-a204-4f67-a4d0-52803148d71a,1.1.7,69.05,72.89,Bronze,TNT: Triple Negative breast cancer Trial,69.05,5f4c825d-d6c3-453e-9667-8cdf2329b6e1,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Gold,100.0,57726e95-afe2-4d62-ab1e-81d90eb0ec1d,1.1.7,95.24,87.16,Gold,COVID-19 Test results,88.89,f5f6d882-163d-4ef1-a53e-000fba409480,20.93,ALLIANCE > SAIL,22.22
Not Rated,17.46,5852d8bc-d721-4daf-a63b-21aebcc6f5a9,1.1.7,21.43,42.11,Not Rated,Tayside & Fife Diabetes – Summary and a range of diabetes related datasets.,40.48,49e63323-e564-48ac-9f11-cf77bf0fe20b,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Not Rated,22.22,59bc96f9-69b7-4763-81a8-ec4695b6b55e,1.1.7,26.19,46.81,Not Rated,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (therapist survey),44.45,bf2d780d-936b-4f4c-88f9-a280b849b652,32.56,ALLIANCE > HQIP,33.33
Silver,92.06,5b5deab2-2a83-4eef-83a8-13853beee94c,1.1.7,85.71,80.06,Silver,National Records of Scotland (NRS) - Stillbirth Data,80.16,dca0c95b-ae7d-4163-8c3b-a881f779df02,25.58,ALLIANCE > PUBLIC HEALTH SCOTLAND,31.75
Bronze,68.25,5b99795a-3db4-4020-a8f9-aa64bcc2c5f0,1.1.7,59.52,64.64,Not Rated,MATCH,66.66,5429fc2a-3d72-414d-9393-4079c4c6c0fa,30.23,ALLIANCE > HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,34.92
Silver,96.83,5b9b7964-615b-438a-b151-d2f884a24aee,1.1.7,92.86,82.47,Silver,North West London Accident and Emergency Data (NWL A&E),81.75,721db252-8069-433d-bb6d-4b44b243d364,27.91,HUB > DISCOVER NOW,33.33
Bronze,60.32,5bb40472-fc5d-4b16-a0a6-d1d42fd1d3e8,1.1.7,69.05,74.06,Bronze,VinCaP,69.84,e57dd7a2-3c5c-4285-8001-8e2589c395e9,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,42.86,5c7ae78d-53e6-427d-a3a9-52538f8342dc,1.1.7,52.38,59.91,Not Rated,International Severe Asthma Registry,54.77,9711e6cc-426c-4cef-afb3-64382f8d7ed4,32.56,HUB > BREATHE,33.33
Silver,69.84,5d2758c6-b315-421f-9971-9df8ba83a2d4,1.1.7,78.57,84.63,Silver,SpiroMeta Consortium Dataset,79.37,fb6d98c5-e41d-4804-bb28-839556e0f657,9.3,HUB > BREATHE,11.11
Silver,85.71,5d76d094-446d-4dcc-baa1-076095f30c23,1.1.7,78.57,73.0,Bronze,Diagnostic Imaging Dataset,76.19,86f46be3-bc29-4820-8363-de6530a94c6f,32.56,ALLIANCE > NHS DIGITAL,33.33
Not Rated,14.29,5e022f8f-4d07-44bb-a87c-43e31200fe1e,1.1.7,16.67,38.57,Not Rated,ARIA Radonc,37.3,59d72237-6969-4f59-9e87-48138978abe8,39.53,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.68
Silver,96.83,5e19a471-64e3-4aa4-ac56-6901d5e39e28,1.1.7,92.86,84.8,Silver,North West London Mental Health Data (NWL MH),83.34,2d3ec99a-a087-4355-8539-5a22cef58910,23.26,HUB > DISCOVER NOW,30.16
Gold,100.0,5e2a7277-dc64-499a-b16d-51850d9ad00b,1.1.7,95.24,87.16,Gold,Emergency Department Dataset Daily,87.3,fa257aa8-51fc-4eb7-a448-e473fa54686d,20.93,ALLIANCE > SAIL,25.4
Silver,87.3,5e9d9633-c4f4-47cc-96d9-350191e18539,1.1.7,80.95,74.19,Bronze,HES Diagnostic Imaging Dataset for CPRD Aurum,76.98,617f9f54-3fb6-40c3-b391-fe51d1fc7c49,32.56,ALLIANCE > CPRD,33.33
Not Rated,22.22,5ea9c568-b850-4589-bcbb-6ee0cfd322cd,1.1.7,26.19,45.66,Not Rated,National Paediatric Diabetes Audit - core clinical dataset (care processes and outcomes),42.86,e355c9b9-44f0-4ba3-a872-645aa88f4f2b,34.88,ALLIANCE > HQIP,36.51
Not Rated,22.22,600be397-211b-4f65-9f82-e85f4393fb8a,1.1.7,26.19,47.98,Not Rated,National Maternity and Perinatal Audit Organisational Survey 2019,45.23,01ad25ed-8cde-43d7-bc77-d8cc3d165df4,30.23,ALLIANCE > HQIP,31.75
Silver,100.0,601f1504-2706-405b-94cb-8cd14231f434,1.1.7,95.24,84.83,Silver,North West London population data (NWL POP),84.92,1032850f-7631-4d9e-a760-b0532bffd21a,25.58,HUB > DISCOVER NOW,30.16
Bronze,60.32,60b148f7-b48c-49c4-9286-b83691cfc7b2,1.1.7,69.05,74.06,Bronze,STAMPEDE,69.84,71eb0192-1124-4b27-86e4-1139e0047a02,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,22.22,61cf3b8d-5a1b-4241-aaac-89599bf17ab6,1.1.7,26.19,47.98,Not Rated,National Clinical Audit of Anxiety and Depression - Core audit of practice,45.23,4a96b9bf-beb0-41b1-9211-e6ce39a21c1a,30.23,ALLIANCE > HQIP,31.75
Bronze,84.13,62087504-c04e-4382-9c71-e1c9b83d2d5e,1.1.7,76.19,71.81,Bronze,Census 2011 E&W - Household structure for COVID-19 models,75.4,2f66bcf9-e626-4e8d-bc6e-2d3958e709d8,32.56,NCS > OFFICE FOR NATIONAL STATISTICS,33.33
Bronze,60.32,62824365-480a-4d20-9ab2-7e7739e7e2ec,1.1.7,71.43,78.74,Silver,ICT-based intervention for adult asthma with limited health literacy,71.43,1d6b02f1-47b8-42ad-919d-f738b545cff7,13.95,HUBS > BREATHE,17.46
Silver,100.0,62c01293-83a5-4d4d-9d36-9d7aa2bf120f,1.1.7,95.24,83.66,Silver,GENOMICS ENGLAND 100K PHE LINKED DATA,84.92,ea748742-568a-46e2-b603-2fada49024e1,27.91,GENOMICS ENGLAND,30.16
Not Rated,22.22,64a0ba4d-776c-4979-a4b0-1f1fb6b61c85,1.1.7,26.19,47.98,Not Rated,National Audit of Dementia Round 4 - organisational checklist,45.23,0a305b29-cf23-4261-9299-5251e41ee9f0,30.23,ALLIANCE > HQIP,31.75
Silver,96.83,64c6a583-f71b-478e-a26b-5e581226ec6d,1.1.7,90.48,83.61,Silver,Higher Education Statistics Agency (HESA) Student Data,84.92,68b04d3b-17b4-4a04-a8a3-e2a93ed231df,23.26,ALLIANCE > SAIL,26.98
Silver,90.48,65481fcf-cc98-44f0-bcfe-c21bcb8db0f5,1.1.7,83.33,74.22,Bronze,HES Accident and Emergency data for CPRD Aurum,77.78,c43501ec-08b4-4d33-a7dd-d19fca821925,34.88,ALLIANCE > CPRD,34.92
Bronze,82.54,65c641db-3271-4f96-8cb4-94cf9e6379b4,1.1.7,73.81,71.79,Bronze,SICSAG Episodes (Scottish Intensive Care Audit Group),73.02,,30.23,ALLIANCE > PUBLIC HEALTH SCOTLAND,36.51
Gold,98.41,65c8a30c-de2c-47bf-87e4-18c86e75e54a,1.1.7,92.86,85.97,Silver,Diagnostic and Therapy Services Waiting Times,86.5,97896866-ab5e-408a-ac5a-072802db9faf,20.93,ALLIANCE > SAIL,25.4
Bronze,60.32,6620b221-6909-4106-a49e-f1b5820be2f3,1.1.7,69.05,74.06,Bronze,interNational Anaplastic Thyroid Cancer Tissue Bank (iNATT),69.84,5ef75d71-73ce-4451-9d7a-a39dd82b712f,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Silver,96.83,664513d6-d766-461d-a69e-206a928cd14f,1.1.7,92.86,78.99,Silver,The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) primary care sentinel network and database,78.58,d5049af5-e351-4b22-8f75-6f3dfc96419b,34.88,ALLIANCE > ROYAL COLLEGE OF GENERAL PRACTITIONERS,39.68
Silver,71.43,67cd0c2b-3944-4bc4-a03a-4081ee67847f,1.1.7,80.95,82.34,Silver,Genetics of Asthma Severity & Phenotypes,77.78,6277abc6-c039-4886-8489-d4a2cdb8190c,16.28,HUB > BREATHE,15.87
Bronze,82.54,67fa61c8-7973-4eb4-999c-fbed084d4445,1.1.7,76.19,71.81,Bronze,Covid-19 Infection Survey,73.02,628e9ad9-28c5-4d58-9ec5-04a63be9b4cf,32.56,NCS > OFFICE FOR NATIONAL STATISTICS,36.51
Gold,100.0,68b34d8f-debe-445b-9ebd-a5a05f277d13,1.1.7,95.24,87.16,Gold,Outpatient Dataset,88.89,d331159b-b286-4ab9-8b36-db39123ec229,20.93,ALLIANCE > SAIL,22.22
Not Rated,46.03,68eca6a2-7c32-4bea-bcd1-c07dc50ee018,1.1.7,52.38,65.72,Not Rated,Exploring the provision of supportive care for patients with COPD in Malaysia,61.91,af8cdc87-789e-4bea-9d8b-927aa689d211,20.93,HUB > BREATHE,22.22
Silver,96.83,6a390359-1e26-470f-a4e5-bfb31a5ed643,1.1.7,92.86,84.8,Silver,North West London Patient Index (NWL PI),84.92,1fe1e7bb-ef6e-4d89-9824-bb560afc81f0,23.26,HUB > DISCOVER NOW,26.98
Bronze,76.19,6a520e77-6607-402c-8272-5c3a20271f13,1.1.7,69.05,70.57,Bronze,Patient Medical Card Registration (NI),74.6,4e5ba567-c452-4979-8e2e-865f7df20252,27.91,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,26.98
Bronze,80.95,6a63513f-92cb-43ce-b0dd-fdb1113150c9,1.1.7,73.81,67.14,Bronze,Mental Health Services Data Set,69.05,fa2ec63d-f76d-4555-8fc1-f4bd66e3c60d,39.53,ALLIANCE > NHS DIGITAL,42.86
Bronze,74.6,6ae22437-38d7-4c47-b529-e100e15c81ab,1.1.7,66.67,69.38,Bronze,Synthetic Dataset: Patients at risk of sudden death: hypertrophic cardiomyopathy,73.02,,27.91,HUB > PIONEER,28.57
Bronze,63.49,6aebcd6d-10c6-44cd-80d6-b5a90791db4f,1.1.7,71.43,75.25,Bronze,York Tissue Bank,71.43,71e898d1-db8c-4887-a605-dd6336b92a34,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,22.22,6b53f274-c927-4b8f-bcc3-1d85fabf16ee,1.1.7,26.19,47.98,Not Rated,National Diabetes Audit - National Diabetes Foot Care Audit clinical dataset,45.23,dabf34b3-7368-4097-94c5-5b4f4be68fc6,30.23,ALLIANCE > HQIP,31.75
Bronze,66.67,6bc36f07-d55a-4a97-afab-29d93dc65bde,1.1.7,76.19,75.31,Bronze,Sheffield Brain Tissue Bank (SBTB),71.43,bdda7221-7c02-4ced-b7a8-3806a073d981,25.58,ALLIANCE > TISSUE DIRECTORY,23.81
Bronze,61.9,6bca5d27-5b98-45e7-b834-6980ba5db5c9,1.1.7,69.05,75.22,Bronze,Leicester Respiratory Research Database,72.22,01c3d08c-6948-4059-a027-3437e4f5d53b,18.6,HUB > BREATHE,17.46
Bronze,60.32,6bde3902-5d69-4c24-9d10-f84a63efdb22,1.1.7,69.05,74.06,Bronze,Leeds Breast Research Tissue Bank,69.84,2dc1218d-df5f-4025-826c-cf5ca7d67882,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,80.95,6c220417-f85b-4538-b1c8-ec9d0582aa8f,1.1.7,76.19,71.81,Bronze,Covid Vaccination Dataset (CVVD),70.64,471f101c-a45e-4620-8710-be3036a46fba,32.56,ALLIANCE > SAIL,39.68
Silver,90.48,6c5c67d5-b7f6-4126-ac5c-be2bf45eb1cc,1.1.7,83.33,80.03,Silver,General Acute Inpatient and Day Case - Scottish Morbidity Record (SMR01),83.34,,23.26,ALLIANCE > PUBLIC HEALTH SCOTLAND,23.81
Bronze,63.49,6ceec25d-2c8e-4dd7-8f99-2e56ec63c298,1.1.7,71.43,72.93,Bronze,DARWIN1 Trial,69.05,7f9672fa-dad5-479d-a929-52719e8cc2fa,25.58,ALLIANCE > TISSUE DIRECTORY,25.4
Not Rated,22.22,6d1b9b23-1197-4857-9b17-9e26cb0633e8,1.1.7,26.19,46.81,Not Rated,National Joint Registry - Revision Elbow Replacement dataset,44.45,12babf2b-42e8-4b1e-9143-3475a07bb343,32.56,ALLIANCE > HQIP,33.33
Not Rated,31.75,6d41700e-6dac-47c1-ba31-eb2f23539efe,1.1.7,35.71,49.25,Not Rated,Emergency Care Dataset (ECDS),47.62,57fa56f2-78d1-49af-ab8d-e8146d711868,37.21,ALLIANCE > BARTS HEALTH,36.51
Not Rated,17.46,6dd0f10d-82fa-438f-ba74-9c880f60bf4c,1.1.7,21.43,42.11,Not Rated,NHS Tayside and Fife Virology,40.48,855a84b2-9d58-4b2b-a450-b6c6d534e403,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Bronze,60.32,6dd6c679-7c5f-4d8e-b1e4-8f1447425e96,1.1.7,69.05,74.06,Bronze,Wales Cancer Bank,69.84,37886fb5-d0ae-400f-89eb-78664897bcf2,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,36.51,6e5916d4-017c-4542-bc71-edf6d4c5a055,1.1.7,40.48,56.28,Not Rated,Biological samples,55.55,41ac38b0-31cd-4865-a357-80ce557b2312,27.91,UK Biobank,25.4
Not Rated,36.51,6ec3a47b-447a-4b22-9b7a-43acae5d408f,1.1.7,42.86,53.99,Not Rated,"Trusted Research Environments for CVD-COVID-UK in England, Scotland and Wales",50.8,7e5f0247-f033-4f98-aed3-3d7422b9dc6d,34.88,OTHER > BHF Data Science Centre,34.92
Not Rated,22.22,6efbc62f-6ebb-4f18-959b-1ec6fd0cc6fb,1.1.7,26.19,47.98,Not Rated,Epilepsy 12 - Patient Reported Experience Measure,45.23,cefa4d82-5a22-4c19-82ab-4663a364e49e,30.23,ALLIANCE > HQIP,31.75
Silver,90.48,6f348bdc-21e4-459b-b658-dc839a1e2133,1.1.7,83.33,77.71,Silver,Intensive Care National Audit and Research Centre,79.37,fa8bf269-4769-491b-b398-fa63137d14ab,27.91,ALLIANCE > SAIL,31.75
Bronze,63.49,7038a67d-34ca-4754-a50f-41aa2849db69,1.1.7,71.43,72.93,Bronze,National Joint Registry - Primary Hip Replacement dataset,69.05,03280e87-6975-4a2a-967d-b332cb788e44,25.58,ALLIANCE > HQIP,25.4
Bronze,60.32,70b4d407-288a-4945-a4d5-506d60715110,1.1.7,69.05,72.89,Bronze,CASPS: A Phase II trial of Cediranib in ASPS patients,69.05,7dcd5c0a-1922-4fe2-9b7e-090e4c39861b,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Bronze,65.08,71b8569c-b582-499c-85aa-909b825f6ea6,1.1.7,73.81,74.12,Bronze,Avon Longitudinal Study of Parents and Children,69.84,255d70c6-9a50-4b62-adc0-44216606a216,25.58,ALLIANCE > AVON LONGITUDINAL STUDY OF PARENTS AND CHILDREN,25.4
Not Rated,14.29,72fe91de-b0c0-423a-ad68-bd7067b20ad8,1.1.7,16.67,38.57,Not Rated,Infoflex Cancer Registry,37.3,5505e91d-9e0a-4969-87d5-00f256d91306,39.53,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.68
Silver,85.71,730b3e54-1f59-4c07-b5d6-e6b63e4dda35,1.1.7,78.57,76.5,Silver,"Deeply-phenotyped hospital COVID patients: severity, acuity, therapies, outcomes",80.16,16a09f1b-3654-4ec3-9913-fb70cb1e2364,25.58,HUB > PIONEER,25.4
Silver,69.84,73462506-32c5-43a0-963e-06d67e967b97,1.1.7,78.57,81.14,Silver,UK BiLEVE Consortium Dataset,76.19,b8bcda0b-3c90-4382-aeb7-b01fc27e58fa,16.28,HUB > BREATHE,17.46
Bronze,53.97,736a9d09-83c7-4cfa-ae82-a10b2a69efc8,1.1.7,61.9,71.65,Bronze,"Prevention, detection, treatment: adult lung disease/cancer in rural Tamil Nadu",66.67,2581994d-5be2-4465-bb62-60c4c97e8e2b,18.6,HUB > BREATHE,20.63
Bronze,100.0,73f54071-62bf-48f5-8be1-569208b18ab8,1.1.7,95.24,74.36,Bronze,HIC Hepatitis v2,73.81,66be725a-b950-4bf8-9a35-7e33ce765a25,46.51,NIHR Health Informatics Collaborative Viral Hepatitis Theme,52.38
Bronze,60.32,74241b17-23b7-4233-b7b9-1a484aa053b0,1.1.7,69.05,74.06,Bronze,Myeloma XII clinical trial samples,69.84,576fbcf8-ff25-4230-ae69-e72ca02b95f1,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,57.14,7480abe4-e073-40ef-882d-217542b5e08e,1.1.7,66.67,74.03,Bronze,Effects of second-hand smoke on pregnant women: a phenomenological study,68.25,4a5c610f-019d-450a-90c5-0fe315027f56,18.6,HUB > BREATHE,20.63
Not Rated,38.1,75614b69-bc18-416b-9d27-fd8ca9fc4521,1.1.7,42.86,56.31,Not Rated,Cancer register,55.56,a4751434-54ea-4d22-a66a-a5d32bd80c40,30.23,UK Biobank,26.98
Not Rated,22.22,76ec0282-02e0-4fff-b016-76bc6ffcb784,1.1.7,26.19,45.66,Not Rated,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (organisational),42.86,3efd9b30-1f84-48c0-a3e0-402ecb5c7724,34.88,ALLIANCE > HQIP,36.51
Gold,100.0,77824298-ef3b-40f7-a0a4-b6dedb2e7a02,1.1.7,95.24,87.16,Gold,The National COVID-19 Chest Imaging Database,88.89,31f0148b-f965-4136-ab39-6c5bbbf8c2d9,20.93,NHSX,22.22
Bronze,63.49,7793f54e-73be-4c97-a941-ba105b1b0480,1.1.7,71.43,75.25,Bronze,Leeds Multidisciplinary Research Tissue Bank,71.43,7e60a651-b3d6-40ef-93dc-1f87dabee7be,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,46.03,7858978f-30e8-42e7-abe4-d9af5447c278,1.1.7,35.71,44.6,Not Rated,NHS Tayside and Fife Haematology Biochemistry (Lab Data Restructured),47.62,10ffac16-d0c2-4d53-ab6a-69a38e283223,46.51,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,50.79
Bronze,63.49,7862c1c2-d4d6-4b3c-aea1-1f15a5b3b5ea,1.1.7,71.43,75.25,Bronze,UCL / UCLH Biobank for Studying Health and Disease,71.43,ce533c67-5565-4010-bedf-dca3863a9084,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Gold,100.0,78ce070c-84db-4676-81c5-0c672f4e12e3,1.1.7,95.24,89.48,Gold,COVID-19 Symptom Tracker Dataset,91.27,594cfe55-96e3-45ff-874c-2c0006eeb881,16.28,ALLIANCE > SAIL,17.46
Not Rated,44.44,78cf87fc-33a5-49b0-bee7-7d8030fe06e8,1.1.7,50.0,61.05,Not Rated,Use of digital auscultation to improve diagnosis of paediatric pneumonia,57.94,198bd2cc-ca40-4dff-992c-a9480703fc37,27.91,HUB > BREATHE,28.57
Not Rated,22.22,78d25670-9d20-4eb7-a79a-f29e53cc981f,1.1.7,26.19,46.81,Not Rated,National Audit of Psychosis - Early Intervention Psychosis Audit patient experience survey,44.45,a464c126-8591-4af6-a10f-99c020f59527,32.56,ALLIANCE > HQIP,33.33
Not Rated,77.78,78fe2e13-7f40-406f-a584-04909d0ce060,1.1.7,64.29,56.57,Not Rated,Mental Health Minimum Dataset v4.1 (Sensitive) Episodes,61.11,efecbe58-4822-4f17-bf5c-92113d143db9,51.16,ALLIANCE > NHS DIGITAL,55.56
Not Rated,34.92,79116473-bda2-413c-82ad-ba2b86e5076f,1.1.7,40.48,57.45,Not Rated,EMEP4UK Pollution,53.18,eb76598f-e228-413c-82f3-231809062611,25.58,HUB > BREATHE,28.57
Silver,92.06,79a7ad18-6941-4543-924a-787f2381f5e0,1.1.7,88.1,77.77,Silver,National Cancer Registration and Analysis Service,78.57,0a852454-ee67-443b-a091-d13499a71b41,32.56,PUBLIC HEALTH ENGLAND,34.92
Bronze,63.49,79b02690-798b-462d-9ced-f53c9e39d624,1.1.7,71.43,74.09,Bronze,Central England Haemato-oncology and oncology Research Biobank (CEHRB),70.64,314953f6-58e7-49c0-adfd-c60e623eba74,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Not Rated,77.78,7aa02796-787a-42c2-b97e-d008fa77e4b8,1.1.7,64.29,56.57,Not Rated,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Records,61.11,1a8fc23c-b67b-4171-b5e1-1b650fce1ef4,51.16,ALLIANCE > NHS DIGITAL,55.56
Bronze,79.37,7aab11a7-6fff-4e4a-a480-b48ccc6bad87,1.1.7,73.81,69.47,Bronze,Moorfields AMD Dataset Release 002,72.22,bf392537-82b4-4d71-ace0-e7bea3b167fb,34.88,HUB > INSIGHT,34.92
Not Rated,22.22,7dc319da-a16f-4e63-a115-0cba3905a322,1.1.7,26.19,45.66,Not Rated,National Asthma and COPD Audit Programme (NACAP): Adult Asthma secondary care clinical dataset,42.86,becd2624-9a01-4f01-bcf8-56e94545a49a,34.88,ALLIANCE > HQIP,36.51
Not Rated,41.27,7df79ee6-e67d-4ad9-89f3-23bee6cb0ec5,1.1.7,47.62,59.86,Not Rated,Effect of personal air pollution exposure on asthma control in children,56.35,57efab41-65fc-4069-8b9d-e5ced13cb4d3,27.91,HUB > BREATHE,28.57
Not Rated,39.68,7e780260-e8d3-4541-b51e-213233dfc349,1.1.7,45.24,57.5,Not Rated,At-Risk Registers Integrated into primary care to Stop Asthma crises in the UK,54.76,36a5da45-772c-4c67-8ec3-84c9e67332d3,30.23,HUB > BREATHE,30.16
Not Rated,22.22,7f125091-12ba-464d-af7d-9a88179b0b95,1.1.7,26.19,46.81,Not Rated,Epilepsy 12 - National organisational audit (service descriptor questionnaire) and Trust profile,44.45,2c737d63-69f4-4a02-8df9-54c1e65e845f,32.56,ALLIANCE > HQIP,33.33
Silver,95.24,7f4fb30c-2a09-4d75-bed2-114751e06723,1.1.7,88.1,80.09,Silver,UHB Eye Image Dataset Release 001,82.54,21fb56d1-726f-40e3-a998-e4b34ba3e46f,27.91,HUB > INSIGHT,30.16
Not Rated,22.22,7fab080b-6e2a-4c82-a5e5-daf99c70662a,1.1.7,26.19,46.81,Not Rated,"National Audit of Dementia - spotlight audit on the prescription of psychotropic medication, 2019",44.45,949d9d7a-a3f1-480a-8563-3fb024300561,32.56,ALLIANCE > HQIP,33.33
Silver,100.0,7fdb684d-bb7a-4d0b-8666-9f10510f071f,1.1.7,95.24,82.5,Silver,GENOMICS ENGLAND 100K CANCER & COMMON,84.12,702f0198-bdfe-401e-97f2-35f5d26357ad,30.23,GENOMICS ENGLAND,31.75
Not Rated,47.62,7fe20f78-758d-4449-beb4-ccf98e2d8247,1.1.7,54.76,68.08,Bronze,Developing Patient and Public Involvement in Research in Malaysia,63.5,153c0ba6-f2ec-4fb4-b5a7-33e11cbdf7fc,18.6,HUB > BREATHE,20.63
Bronze,82.54,80a7208f-c174-42bd-9127-e8f006de7c95,1.1.7,76.19,74.14,Bronze,COVID-19 Test Trace and Protect [CTTP],75.4,c0fc84af-aeab-4c7e-aa0b-8264baff55d9,27.91,ALLIANCE > SAIL,31.75
Bronze,80.95,80b54fc9-8dc0-4134-880d-ffa8d4473204,1.1.7,71.43,69.44,Bronze,NHS Scotland General Practice (GP) Contact Data - Subset,69.84,8f486c3d-9504-4a0e-8e24-ab96f057fc9e,32.56,ALLIANCE > PUBLIC HEALTH SCOTLAND,41.27
Gold,100.0,80e9c439-4909-4534-8bfe-6f01fdec7de7,1.1.7,95.24,88.32,Gold,Cervical Screening Wales,89.69,b32325d7-7f00-4d20-9935-dd02e1bc6932,18.6,ALLIANCE > SAIL,20.63
Silver,90.48,81a2abb5-e2b4-4224-8345-5aac1dc68a5d,1.1.7,83.33,73.06,Bronze,Systemic Anti-Cancer Treatment (SACT) data for CPRD GOLD,76.98,014e7973-b43e-4a4a-91b4-de3f353b71b9,37.21,ALLIANCE > CPRD,36.51
Silver,84.13,81c54c5a-ceb1-487c-820a-437b4dd002ca,1.1.7,76.19,74.14,Bronze,Risk and outcomes of coagulopathies in acutely unwell adults,78.57,bf3fe16c-5377-4571-b5a5-7aa7e796594c,27.91,HUB > PIONEER,26.98
Silver,88.89,81f3bdfe-de6b-4831-ba9a-4e28a34a6ab4,1.1.7,83.33,74.22,Bronze,HES Outpatient data for CPRD GOLD,76.98,21dc2345-3983-4a46-960c-f17974bc7b71,34.88,ALLIANCE > CPRD,34.92
Not Rated,77.78,8226b6fa-d815-4f15-9064-b56beb0fddb1,1.1.7,64.29,56.57,Not Rated,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Episodes,61.11,a27400b0-0efb-4af8-a7bc-e2c7e59796e3,51.16,ALLIANCE > NHS DIGITAL,55.56
Bronze,66.67,826114ca-2563-4c0c-b023-3417ead32956,1.1.7,76.19,75.31,Bronze,Research Donors Ltd,71.43,fcb62cb3-c876-47a3-961e-fb27c6f718fa,25.58,ALLIANCE > TISSUE DIRECTORY,23.81
Not Rated,22.22,82665c1e-df7f-4136-a05f-0826533149e5,1.1.7,26.19,47.98,Not Rated,National Audit of Dementia Round 4 - staff questionnaire,45.23,ef6e68d6-dcba-410c-943c-26ca21376a3a,30.23,ALLIANCE > HQIP,31.75
Gold,100.0,8270e26b-65ea-479c-8462-f5315b2657eb,1.1.7,95.24,88.32,Gold,National Exercise Referral Scheme,89.69,131784c0-769d-4f7b-b7d0-b5f4b89886d4,18.6,ALLIANCE > SAIL,20.63
Bronze,79.37,82b0be0d-3bd3-4a4e-a37d-be4c3b8a42f7,1.1.7,71.43,72.93,Bronze,Labour Force Survey (Person),75.4,8c60a308-1e47-4a0c-8b69-9259f05338cb,25.58,NCS > OFFICE FOR NATIONAL STATISTICS,28.57
Bronze,63.49,82f4cf19-9e6a-4c31-8cc3-085f3d44ba44,1.1.7,71.43,75.25,Bronze,Northern Ireland Biobank (NIB),71.43,c6e1ea88-f5bf-4a57-953f-688f313fcb04,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Silver,100.0,844f3be0-f50d-4a88-9783-0928ad1c2aad,1.1.7,95.24,75.53,Bronze,HIC Acute Coronary Syndromes,76.19,869a9b4e-3537-449f-9a59-a0eac523c4e4,44.19,NIHR Health Informatics Collaborative Cardiovascular Theme,47.62
Bronze,60.32,8466ec6f-8a4c-4286-8138-04c35e12b1f8,1.1.7,69.05,74.06,Bronze,"Oncology Clinical Trials Office, University of Oxford",69.84,4a65f6d6-f2e4-4d98-a3a4-94a32206836d,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,39.68,84b6d047-2a05-4fc0-8537-809dbb3d18ed,1.1.7,45.24,59.83,Not Rated,COMPARE,57.94,8cbb73e2-a2c4-4caf-8dcd-6ac3795bb996,25.58,OTHER > The University of Cambridge,23.81
Not Rated,14.29,84de0d13-f5bd-4c22-83d3-e1adb00d5a72,1.1.7,16.67,38.57,Not Rated,CRIS,37.3,67cea834-33f5-4ed7-9dc2-072ad077de07,39.53,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.68
Silver,96.83,850f99cb-f091-4f10-86ee-06a3eaa7df53,1.1.7,92.86,83.64,Silver,North West London Coordinate My Care (NWL CMC),84.13,c853b41b-fbd1-4896-b0fb-85303109fec4,25.58,HUB > DISCOVER NOW,28.57
Not Rated,22.22,858c517e-8ce3-4059-9326-d158489e48d1,1.1.7,26.19,47.98,Not Rated,National Diabetes Audit - National Diabetes in Pregnancy clinical Audit dataset,45.23,7c789df2-46f0-4e0e-b6ff-b04dce801445,30.23,ALLIANCE > HQIP,31.75
Silver,100.0,8638e095-a609-463f-b36e-c4cac4519660,1.1.7,95.24,83.66,Silver,Cystic Fibrosis Patient Tendon Rupture,81.75,4fcc8b11-2b9b-4f68-b51a-978749d89acc,27.91,ALLIANCE > CYSTIC FIBROSIS TRUST,36.51
Bronze,60.32,865f0e79-f862-493b-b863-b39b777d60ca,1.1.7,69.05,72.89,Bronze,Oxford Musculoskeletal Biobank,69.05,ccd6e59d-3582-4f47-a4cd-f5845192d75c,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Silver,68.25,8665b36e-f9a5-4062-ba56-d33fecfe3376,1.1.7,78.57,82.31,Silver,Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS),76.98,cc6f926a-90cf-4083-84e7-131d1e63813b,13.95,HUB > BREATHE,14.29
Silver,93.65,8697d105-4b32-4e7f-9998-8df4250cb3e5,1.1.7,85.71,81.22,Silver,Scottish Stillbirth and Infant Death Survey,83.34,e54d35a6-2e7c-422d-a4a5-a7da930b08f2,23.26,ALLIANCE > PUBLIC HEALTH SCOTLAND,26.98
Not Rated,76.19,86d7088b-7a15-4e9a-b2b0-857a67e04650,1.1.7,64.29,60.05,Not Rated,HES:Civil Registration (Deaths) bridge,64.28,21aec912-444f-447d-b3c4-6791a6c82667,44.19,ALLIANCE > NHS DIGITAL,47.62
Not Rated,22.22,875999d5-f5ed-4136-ac20-b20f1abe27dd,1.1.7,26.19,46.81,Not Rated,National Early Inflammatory Arthritis Audit - clinical dataset,43.65,b0797c05-352f-455f-8d27-150b6f6354cc,32.56,ALLIANCE > HQIP,34.92
Silver,90.48,88155e0d-a88f-4a72-ba3f-45d4e352439a,1.1.7,83.33,73.06,Bronze,Cancer registration data for CPRD GOLD,76.98,e2f5d637-94b3-447b-b7eb-ea957ce449b6,37.21,ALLIANCE > CPRD,36.51
Bronze,60.32,88576066-fb5f-43e2-8af4-0904630b2f1b,1.1.7,69.05,74.06,Bronze,University of Southampton Faculty of Medicine Tissue Bank,69.84,786563e9-5377-4d18-8d32-65ff14d53987,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Silver,90.48,8895d3d9-78bd-4216-986a-3bb7f864c382,1.1.7,83.33,74.22,Bronze,HES Accident and Emergency data for CPRD GOLD,77.78,733b1060-f958-4c3e-ab6a-2b87901d9a9a,34.88,ALLIANCE > CPRD,34.92
Not Rated,77.78,895e5c2f-e484-4d08-91c6-35ac2f85c231,1.1.7,64.29,56.57,Not Rated,Mental Health Minimum Dataset v2.6 (Non-Sensitive),61.11,702201ff-e729-4e29-a428-32953c9a0332,51.16,ALLIANCE > NHS DIGITAL,55.56
Bronze,60.32,89aac17d-f8a1-4ddc-9495-4adc278234a9,1.1.7,69.05,74.06,Bronze,Human Biomaterials Resource Centre,69.84,2f085ac6-d33d-4b9b-8a99-624cc51c3f17,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,77.78,89d76819-32cb-48ad-9337-880f324a6ec0,1.1.7,69.05,69.41,Bronze,Northern Ireland Regional Maternity system (NIMATS),73.81,be7efa4f-e500-4a54-8157-6c4442a7e8a8,30.23,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,30.16
Silver,85.71,89f76cff-03dd-47a1-b6fc-29e42b78e7a5,1.1.7,78.57,73.0,Bronze,Hospital Episode Statistics Admitted Patient Care,76.19,2b6409db-a669-4bef-9fd5-39c2b6f8d5e9,32.56,ALLIANCE > NHS DIGITAL,33.33
Not Rated,17.46,8a128e75-0188-40a3-94d4-5f1967fcffb2,1.1.7,21.43,42.11,Not Rated,Fife Radiology,40.48,d020302b-a691-49fb-9d10-1274af2f3110,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Not Rated,15.87,8a91286f-3d29-40fc-ae5b-196c46a50426,1.1.7,19.05,37.43,Not Rated,CDE Documentation,36.51,f866b225-10b8-4df4-9c32-072411f816d8,44.19,ALLIANCE > BARTS HEALTH,42.86
Gold,100.0,8bbcf9f4-a3c4-4f26-aa0e-c5c46457afa3,1.1.7,95.24,87.16,Gold,COVID-19 Consolidated Deaths,87.3,70e37f44-5c3e-4c83-a42a-89b3476d1d45,20.93,ALLIANCE > SAIL,25.4
Bronze,85.71,8c573599-30cf-4708-bcbd-e2e37c795664,1.1.7,78.57,73.0,Bronze,NIHR BioResource: Demographic,75.39,d2c486bb-b95b-4093-bb58-b196cfc08c7b,32.56,ALLIANCE > NIHR BIORESOURCE,34.92
Not Rated,15.87,8c7abca7-4292-4d1f-b311-c132a7adf109,1.1.7,19.05,38.59,Not Rated,Sectra PACS,37.3,10bf4c08-6702-44fe-8faa-1280dea6b0c9,41.86,ALLIANCE > BARTS HEALTH,41.27
Silver,82.54,8cfbaeec-98ce-4e09-b49c-d7c5968f1e85,1.1.7,76.19,79.95,Silver,Child Health Systems Programme - 6-8week review,82.54,f9cf4be7-fbc9-4601-8beb-5d3c3596bf04,16.28,ALLIANCE > PUBLIC HEALTH SCOTLAND,17.46
Silver,88.89,8d06cb09-640c-40db-8387-adf7fab54c3b,1.1.7,80.95,75.36,Bronze,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes (Gold),80.16,83059be4-071b-4a36-8ab1-9fde1e32e75e,30.23,ALLIANCE > CPRD,28.57
Silver,88.89,8d24889c-ac3c-4b9d-a8bd-cf9effd64370,1.1.7,80.95,75.36,Bronze,Quality of Life of Cancer Survivors: Pilot Patient Reported Outcomes (Aurum),80.16,3bc43876-507b-4dff-bd2b-7df147322e15,30.23,ALLIANCE > CPRD,28.57
Not Rated,77.78,8d3f80d4-aeae-46f0-809b-cd6c51e24f75,1.1.7,64.29,58.89,Not Rated,Bridge file: Hospital Episode Statistics to Mental Health Minimum Data Set,64.28,31bb8022-f8b1-405a-a22f-140f7c4b4fa6,46.51,ALLIANCE > NHS DIGITAL,49.21
Bronze,79.37,8dafbcb0-7876-4f71-8b54-eabf7d441080,1.1.7,73.81,70.62,Bronze,Covid Lateral Flow Test (CVLF),68.25,,32.56,ALLIANCE > SAIL,42.86
Not Rated,69.84,8e5e3ebe-c0ae-458f-bc75-a5a3368d4c2d,1.1.7,61.9,63.51,Not Rated,REal-time Assessment of Community Transmission (REACT-2),65.08,25003f25-384c-4264-9c8f-dd8734ee5595,34.88,ALLIANCE > IMPERIAL COLLEGE LONDON,39.68
Not Rated,46.03,8eace3c2-1dc8-4708-9350-ad129b7d2bc9,1.1.7,47.62,54.05,Not Rated,Mental Health Services Data Set - Inpatients,54.76,275ac6a4-798b-4f49-a25e-008245050bbc,39.53,ALLIANCE > NHS DIGITAL,36.51
Silver,84.13,8fac682b-96be-4e21-a2a9-5fe66c3b35ff,1.1.7,76.19,74.14,Bronze,The impact of hospitalised patients with COPD: from admission to outcome,78.57,780bf7d0-9ee1-4641-a74f-dc148e361970,27.91,HUB > PIONEER,26.98
Bronze,58.73,8fc0a2cc-a8ce-4558-a98a-c514255833d8,1.1.7,69.05,77.55,Silver,Pneumonia case management practices in selected communities in Pakistan,70.63,cf190350-74c6-45f2-8ede-69ace62eb88d,13.95,HUB > BREATHE,17.46
Bronze,63.49,914321d0-1d86-4974-a38d-97469f9ff2cd,1.1.7,71.43,75.25,Bronze,Bloodwise Childhood Leukaemia Cell Bank,71.43,93baeb13-cc4b-47fd-9dae-5ae5277cba54,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,22.22,91479cbf-664e-4782-8514-a3247bb5c4f4,1.1.7,26.19,45.66,Not Rated,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - organisational audit,42.86,4b33fc6d-3cac-4404-adac-d693328456fa,34.88,ALLIANCE > HQIP,36.51
Not Rated,52.38,91f1aef1-7dfe-4cb3-86ab-15e09f91e969,1.1.7,59.52,66.97,Bronze,Seasonal Influenza Vaccine Effectiveness II,62.7,50b47298-d935-4990-a002-e26b6bb26d30,25.58,HUB > BREATHE,26.98
Not Rated,22.22,92d95f82-50a5-4df9-914a-ca26b14cf84c,1.1.7,26.19,47.98,Not Rated,National Diabetes Audit - Core Clinical Audit Dataset,45.23,f4c8900b-5db5-4426-95e9-2f1617c92a76,30.23,ALLIANCE > HQIP,31.75
Silver,96.83,931efe47-04eb-4ff3-aa62-97e2e4007aed,1.1.7,92.86,82.47,Silver,Yorkshire Specialist Register of Cancer in Children and Young People,80.95,93582beb-e45a-47b6-aeab-d26f583e4c3b,27.91,HUB > DATA-CAN,34.92
Bronze,77.78,9353805b-753d-486d-a2ff-3aa23d4ab197,1.1.7,69.05,68.25,Bronze,Enhanced Prescribing Database,73.02,2843087f-23a4-4cfe-8e72-53f2b9562cc3,32.56,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,31.75
Gold,100.0,9360bc6c-2a7d-4415-869d-3e853c558f4d,1.1.7,95.24,85.99,Silver,National Survey for Wales,86.51,bcca421a-9077-4c47-9daa-b1bc030d3dee,23.26,ALLIANCE > SAIL,26.98
Not Rated,46.03,93ad5a26-65f5-438f-b4e3-9f7078cc2f92,1.1.7,35.71,44.6,Not Rated,Demography,47.62,b88c2b24-b75d-4d28-9391-2dbac1605a17,46.51,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,50.79
Not Rated,34.92,93d26255-7199-4ea7-997d-f74890d12b87,1.1.7,38.1,55.09,Not Rated,Imaging,54.76,32a2dcb1-1e18-44ba-ad49-b3da312ca447,27.91,UK Biobank,25.4
Bronze,60.32,9445e723-655a-43d0-a4e5-50313d98eac0,1.1.7,69.05,72.89,Bronze,National Unified Renal Translational Research Enterprise (NURTuRE),69.05,15f07cef-f4cc-4a50-90bc-9fd40f8b6327,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Bronze,60.32,94e28efd-a976-4748-81fd-956a598c26cb,1.1.7,69.05,74.06,Bronze,BioDock,69.84,ecb82441-286f-408d-880c-9239a25fb5cd,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Silver,87.3,94f983ec-af41-451a-af5d-657ac58207c6,1.1.7,80.95,80.01,Silver,Unscheduled Care Datamart,83.34,,20.93,ALLIANCE > PUBLIC HEALTH SCOTLAND,20.63
Bronze,63.49,94fab6d3-9753-4ffd-ade2-02d199d93f94,1.1.7,71.43,75.25,Bronze,RAPPER,71.43,76d26f0f-0136-4ae5-8be9-37782a70bac5,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,88.89,9552365b-7b9a-4d04-a857-358d0e171424,1.1.7,80.95,70.71,Bronze,Pregnancy Register for CPRD GOLD,73.81,14aaf184-5922-4459-affb-6c9e55c12176,39.53,ALLIANCE > CPRD,41.27
Bronze,69.84,96c73136-da1b-43de-9fd1-9d5e63631b14,1.1.7,59.52,63.48,Not Rated,VIVALDI 2,67.46,12f1ffbc-0ddd-4d6e-b126-2cccf6738658,32.56,OTHER > UNIVERSITY COLLEGE LONDON,34.92
Silver,90.48,9709ee81-c5f1-4c01-a1ac-51ae2a0a60f3,1.1.7,83.33,77.71,Silver,SAIL Dementia e-Cohort,80.96,f48b7c05-6a44-480c-84c6-4f7a684f29f8,27.91,ALLIANCE > SAIL,28.57
Silver,92.06,97ae3443-b60b-4b33-b861-83663caea1dc,1.1.7,85.71,75.41,Bronze,HES Admitted Patient Care data for CPRD GOLD,78.57,4bcf64a6-f404-4ef4-ae6e-172512ab5f43,34.88,ALLIANCE > CPRD,34.92
Not Rated,77.78,97fa09e6-5ea5-41cd-baf8-20366db13a3f,1.1.7,64.29,56.57,Not Rated,Mental Health Minimum Dataset v4 (Sensitive) Records,61.11,eab996ed-b268-439a-bff4-19925698336a,51.16,ALLIANCE > NHS DIGITAL,55.56
Bronze,63.49,99812cec-ea1c-4979-8e00-32df5bad000b,1.1.7,73.81,75.28,Bronze,RATHL Trial,70.64,e5ec63dd-4da5-4119-99c8-5cc79045618c,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Not Rated,22.22,9a4ef776-6b4b-40cd-9c88-cbf1128780e9,1.1.7,26.19,46.81,Not Rated,National Bowel Cancer Audit - clinical dataset,44.45,c8a28f0b-a5f8-4dbb-8d71-5b89c7cb3111,32.56,ALLIANCE > HQIP,33.33
Silver,88.89,9a5fdb85-7bd6-4073-9058-e45667d497a8,1.1.7,80.95,74.19,Bronze,Quality of Life of Colorectal Cancer Survivors: Patient Reported Outcomes (Gold),77.78,61a607a9-b404-41e0-a52e-0c6d0ce8c2be,32.56,ALLIANCE > CPRD,33.33
Silver,85.71,9a9eb7dd-c9fd-4132-963c-c0459a9b21d8,1.1.7,78.57,73.0,Bronze,Hospital Episode Statistics Accident and Emergency,76.19,3ddfccc3-ba32-4653-a999-966b8d6c412f,32.56,ALLIANCE > NHS DIGITAL,33.33
Bronze,76.19,9abe7041-2502-4fc0-b407-7603caecaf67,1.1.7,66.67,68.22,Bronze,Emergency Department (Symphony),71.43,8002b4d7-ff3b-4402-b805-a6a0022836fd,30.23,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,33.33
Bronze,84.13,9ad4cc56-e86f-4d96-a515-05ee37edc1e9,1.1.7,78.57,74.17,Bronze,Coronavirus and the social impacts on Great Britain,74.6,e253257c-48c2-491b-b3b9-205161a16a7e,30.23,NCS > OFFICE FOR NATIONAL STATISTICS,34.92
Not Rated,46.03,9b7f7994-0b9c-4809-b67d-45ae1f04ec5c,1.1.7,47.62,54.05,Not Rated,Mental Health Services Data Set - Currencies,54.76,add485fa-4c54-4a3e-8676-abe2ff4725a5,39.53,ALLIANCE > NHS DIGITAL,36.51
Not Rated,20.63,9beca627-12cd-4231-8638-93cf0bdfa413,1.1.7,23.81,43.3,Not Rated,National Asthma and COPD Audit Programme (NACAP):COPD and adult asthma secondary care organisational dataset,41.27,1982d9ef-890a-41ff-a86a-de61d65aaa09,37.21,ALLIANCE > HQIP,38.1
Bronze,85.71,9bfba8a4-43c3-4356-93a5-3eb3b7bc247a,1.1.7,78.57,71.84,Bronze,PHM and Cancer Outcomes in the WYH Cancer Alliance,74.6,bc839e9c-e303-4c3c-9c2c-9975602376e2,34.88,HUB > DATA-CAN,36.51
Not Rated,22.22,9c0f13ca-5831-4d9b-860a-7d856be7a9f1,1.1.7,26.19,45.66,Not Rated,Falls and Fragility Fracture Audit Programme National Hip Database clinical dataset,42.86,e06b951b-e9d8-4a2c-a51f-1d819f669205,34.88,ALLIANCE > HQIP,36.51
Gold,100.0,9ca6e8d2-98d2-4757-84e1-287585400e55,1.1.7,95.24,87.16,Gold,"Extended Cohort for E-health, Environment and DNA (EXCEED)",88.09,e22ddf52-7f9e-4072-ae61-cb722461b37d,20.93,HUB > BREATHE,23.81
Not Rated,17.46,9ce35921-a1de-444b-a822-c0f6a8003797,1.1.7,21.43,42.11,Not Rated,Tayside Pathology,40.48,419e5a82-2d82-48a7-a8f3-a83e64a54e92,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Silver,95.24,9d4f445e-f81e-45d7-bd83-7e9f68199b4f,1.1.7,90.48,82.45,Silver,IBD NIHR BioResource: Sample holding,83.34,f2af20f9-af84-40ce-8a07-7d095948653e,25.58,HUB > GUT REACTION,28.57
Not Rated,44.44,9de20d42-8e9b-45c8-8574-52a49fba826c,1.1.7,52.38,62.23,Not Rated,Respiratory social media database,57.94,43fc768a-9d2c-4c6d-952f-d8570c487b4a,27.91,HUB > BREATHE,28.57
Silver,100.0,9e67001e-7c77-4bc0-9af2-5138b5d638e4,1.1.7,95.24,85.99,Silver,Annual District Death Daily,85.72,584bf8c8-d58f-44c6-9b65-e1611144fd54,23.26,ALLIANCE > SAIL,28.57
Silver,87.3,9f7608a0-2424-457d-ba50-f51a4444403b,1.1.7,78.57,73.0,Bronze,Patient postcode linked deprivation measures for CPRD GOLD,78.57,f5c9ba01-a9cb-4a85-9850-d9466b2ff4fb,32.56,ALLIANCE > CPRD,30.16
Not Rated,22.22,a05443cd-e292-4b5f-b1f1-95718e300d46,1.1.7,26.19,46.81,Not Rated,National Early Inflammatory Arthritis Audit - patient survey,43.65,e87410ec-a819-43db-99d1-f887c977e525,32.56,ALLIANCE > HQIP,34.92
Bronze,60.32,a06afa88-caba-4354-ac70-d05c67b34dfc,1.1.7,69.05,74.06,Bronze,UK CLL Trials Biobank,69.84,636e216a-072b-4c8b-b867-23b7666d2cb2,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,98.41,a0e0c0c2-072a-47ac-9252-e27b37ac024f,1.1.7,92.86,70.85,Bronze,HIC Transplantation,69.84,359a322e-3781-4796-b6b2-81962fa19b7a,51.16,NIHR Health Informatics Collaborative Renal Transplantation Theme,58.73
Bronze,80.95,a10eeef3-8338-4ec1-b146-8f72a369b841,1.1.7,71.43,69.44,Bronze,COVID19 Vaccination Status,72.22,98372a87-f3e6-475d-be12-46c0f9587413,32.56,ALLIANCE > NHS DIGITAL,36.51
Silver,87.3,a1164dbd-4057-45a2-9860-cbb69696bd7c,1.1.7,80.95,74.19,Bronze,HES Patient Reported Outcomes Measures (PROMs) data for CPRD GOLD,76.98,2439a88e-d961-4152-a7b5-042097946209,32.56,ALLIANCE > CPRD,33.33
Not Rated,34.92,a11a234b-8b59-41e8-920a-f8f1799d3c77,1.1.7,38.1,55.09,Not Rated,Biological sample assays,54.76,14c697a5-2d41-4d86-bf17-2e596d07418b,27.91,UK Biobank,25.4
Bronze,85.71,a182b27f-5000-40f0-8afd-f2f193a31b7d,1.1.7,78.57,71.84,Bronze,NIHR BioResource: Case report form,73.02,4b8675d3-dd87-4cca-804c-aaf0e4ff8140,34.88,ALLIANCE > NIHR BIORESOURCE,39.68
Not Rated,77.78,a1a67182-e81b-4144-ac51-92a86f277eb2,1.1.7,64.29,56.57,Not Rated,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Events,61.11,7b31b427-b447-432e-9a6c-ad2099343491,51.16,ALLIANCE > NHS DIGITAL,55.56
Gold,100.0,a1e1ec62-d78c-40ac-9f90-66ef1dd865b2,1.1.7,95.24,88.32,Gold,Brecon dataset,89.69,9c6e891f-6449-48d2-a1c3-8dd236e34bbd,18.6,ALLIANCE > SAIL,20.63
Bronze,80.95,a28cf3ca-8bad-45bb-bca0-78b4d22fed69,1.1.7,73.81,69.47,Bronze,Death registration data - Provisional Monthly Extracts,71.42,487222b7-5c13-4a92-8b41-044796048720,34.88,NCS > OFFICE FOR NATIONAL STATISTICS,38.1
Silver,100.0,a337845e-1dde-445b-90cf-91d8b825e3a5,1.1.7,95.24,85.99,Silver,Comprehensive Patient Records for Cancer Outcomes,85.72,ce4582a8-0985-46c6-b95f-29a5de862d4a,23.26,HUB > DATA-CAN,28.57
Gold,100.0,a45acd02-82d7-4bfe-9845-6b4df683bba8,1.1.7,95.24,88.32,Gold,Care Home Dataset,89.69,aae02f9e-1bad-415d-9730-c46a07a990aa,18.6,ALLIANCE > SAIL,20.63
Bronze,80.95,a4eb97a6-6a61-415b-9dfb-65503675ed00,1.1.7,76.19,74.14,Bronze,Health & Attainment of Pupils in a Primary Education Network [HAPN],75.4,464d8653-4e69-406b-93fd-d68c29d5dfdc,27.91,ALLIANCE > SAIL,30.16
Bronze,63.49,a5163bce-7c03-4e61-8ebc-024939c047a8,1.1.7,71.43,75.25,Bronze,UK ME/CFS Biobank,71.43,d0694e15-b6ba-4a95-962a-dbf627ca207c,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Silver,85.71,a53b2f7a-c4a6-4914-9adb-17946c58afad,1.1.7,76.19,70.66,Bronze,Rural-Urban classification for CPRD GOLD,76.98,a7d8c6a8-0825-4e73-8f29-3d76194d7114,34.88,ALLIANCE > CPRD,31.75
Bronze,80.95,a5bd43e6-c364-4bee-b529-a75ed97adf4d,1.1.7,76.19,72.98,Bronze,Welsh Results Reports Service (WRRS),73.02,,30.23,ALLIANCE > SAIL,34.92
Not Rated,23.81,a5c088cd-dae6-4c58-b381-a0d273585f4d,1.1.7,28.57,46.84,Not Rated,The Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease,44.45,d472a895-8587-4503-956e-3bd66d990979,34.88,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,34.92
Not Rated,68.25,a638f8a0-3527-49a8-a269-06db49f051c6,1.1.7,59.52,63.48,Not Rated,Sars-CoV-2 Immunity & REinfection EvaluatioN (SIREN),65.87,8e0221d4-dcfa-4580-834b-f44421fca3b5,32.56,ALLIANCE > PUBLIC HEALTH ENGLAND,36.51
Bronze,60.32,a6472a29-17db-477c-bb6e-264686c8fc26,1.1.7,69.05,72.89,Bronze,plasmaMATCH,69.05,5618f65d-23fc-4bd5-9a4c-73e4b330c3a6,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Not Rated,44.44,a6ea7b88-bb80-4a85-a5b9-b5cf05620f6d,1.1.7,50.0,61.05,Not Rated,Enhancing access to pulmonary rehabilitation through implementation research,57.94,6265a41f-9444-457b-b401-1d0978f5c58a,27.91,HUB > BREATHE,28.57
Not Rated,14.29,a74f72ad-bf70-42e4-8933-069c7b53c7f9,1.1.7,16.67,38.57,Not Rated,LIMS,37.3,df70b490-3c00-458e-a6dd-ea3242a3ebac,39.53,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.68
Silver,87.3,a79944dc-2696-4326-b378-dbd9224635f1,1.1.7,80.95,74.19,Bronze,HES Patient Reported Outcomes Measures (PROMs) data for CPRD Aurum,76.98,7958450d-bd25-42c4-b79e-0e3d0806ac21,32.56,ALLIANCE > CPRD,33.33
Not Rated,66.67,a7b56c3d-e55e-4e57-bdc2-490b537f87fb,1.1.7,57.14,61.13,Not Rated,Improving Access to Psychological Therapies Data Set,65.08,bcf6e5ce-986d-4b84-9c9c-69de966e8bbd,34.88,ALLIANCE > NHS DIGITAL,36.51
Silver,100.0,a7ddefbd-31d9-4703-a738-256e4689f76a,1.1.7,95.24,87.16,Gold,HDR UK Papers & Preprints,85.72,fd8d0743-344a-4758-bb97-f8ad84a37357,20.93,OTHER > HEALTH DATA RESEARCH UK,28.57
Gold,100.0,a806b304-1008-4fea-887a-15e49c42161d,1.1.7,95.24,87.16,Gold,GP dataset - Welsh Primary Care,88.89,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2,20.93,ALLIANCE > SAIL,22.22
Bronze,53.97,a807ff6d-bdcd-4649-a9d2-b7bc6dfb9a5b,1.1.7,61.9,75.14,Bronze,Scottish Immunisation Recall System (SIRS),70.63,c027d0ca-7c7d-4864-b4dd-8040f4020fbb,11.63,ALLIANCE > PUBLIC HEALTH SCOTLAND,12.7
Not Rated,22.22,a895be78-f41c-40b8-b2fa-678a071a6427,1.1.7,26.19,45.66,Not Rated,National Asthma and COPD Audit Programme (NACAP): primary care workstream resources,42.86,8a3ec96a-0600-4c6d-8761-9d277f07b9da,34.88,ALLIANCE > HQIP,36.51
Gold,98.41,a8bb670a-b45b-48a6-8e4d-9e8f61de4f5b,1.1.7,92.86,85.97,Silver,Healthcare Workers Risk Assessment,88.09,ed131fee-0635-4613-a453-a383d5dd7cec,20.93,ALLIANCE > SAIL,22.22
Not Rated,55.56,a8f5117e-7523-452f-abf3-ced72f03cb2e,1.1.7,61.9,68.16,Bronze,Salford Lung Study,65.08,86838cad-d5d3-4b65-9c37-29b0c8c36309,25.58,HUB > BREATHE,25.4
Bronze,80.95,a9317016-d985-4957-ac3a-2427722544a4,1.1.7,71.43,69.44,Bronze,COVID19 Vaccination Adverse Reaction,72.22,080a90e4-4bc6-4153-a4c6-c120eef5ba94,32.56,ALLIANCE > NHS DIGITAL,36.51
Silver,90.48,a971ac7b-04e5-4bd5-8bfa-b456d5ed4dbf,1.1.7,83.33,80.03,Silver,Scottish Cancer Registry (SMR06),83.34,ad36dc03-1856-44de-99b0-1af6f312d86b,23.26,ALLIANCE > PUBLIC HEALTH SCOTLAND,23.81
Silver,82.54,a9b50e33-9974-4635-8e52-9c9b3cb87eb2,1.1.7,73.81,72.95,Bronze,"Demography, interventions & outcomes of patients with Cerebrovascular Disease",77.78,ddf7f82f-b453-442d-b562-bb0157593831,27.91,HUB > PIONEER,26.98
Silver,96.83,a9f4a852-a1f2-4041-bb33-3a50e6c43f8d,1.1.7,92.86,83.64,Silver,North West London Primary Care Events Data (NWL PCE),84.13,0f930154-0a0e-4bef-9464-59e657b904d6,25.58,HUB > DISCOVER NOW,28.57
Not Rated,77.78,aa019da2-0f2f-493c-95e8-7263ee735f46,1.1.7,64.29,56.57,Not Rated,Mental Health Minimum Dataset v3_3.5 (Non-Sensitive),61.11,348b12fb-7718-477e-a572-4fc3c716152d,51.16,ALLIANCE > NHS DIGITAL,55.56
Silver,88.89,aa1fe6a9-79cc-4afc-bd38-ec0d5e4fc195,1.1.7,80.95,75.36,Bronze,ONS 2011 Census Wales (CENW),76.19,fc24482c-0f9b-445f-af7a-8598627c3b15,30.23,ALLIANCE > SAIL,36.51
Not Rated,17.46,aa5c8e81-ad02-4366-9577-472f7ed339d9,1.1.7,21.43,42.11,Not Rated,Fife Microbiology: Tests,40.48,0c43c0b6-de3a-478b-8190-4da37fbe5ff5,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Silver,84.13,ac5aba4a-3e34-4e44-b8e7-1e9410e7ff0c,1.1.7,76.19,72.98,Bronze,"Ventilatory strategies, medications and outcomes for patients with COVID",76.19,,30.23,HUB > PIONEER,31.75
Not Rated,74.6,acafb160-b18a-436e-90f1-dc4530a90267,1.1.7,61.9,57.7,Not Rated,Mental Health Minimum Data Set,64.28,285ae0ae-196b-4a75-b1f1-78b07162acfa,46.51,ALLIANCE > NHS DIGITAL,46.03
Not Rated,36.51,acd433ab-51a7-445b-8700-fbce57d82a29,1.1.7,42.86,58.64,Not Rated,Covid Immunisation,54.77,e1a6c1e1-1cec-49cd-aea0-37d4ff56435d,25.58,NCS > OFFICE FOR NATIONAL STATISTICS,26.98
Silver,84.13,ad376d74-4f12-4fb4-8d34-a9e7d0b45b3b,1.1.7,76.19,72.98,Bronze,COVID-19 SARI-Watch (formerly CHESS),76.19,f61f116d-f732-450e-9d34-c6ae00e3fd1e,30.23,ALLIANCE > NHS DIGITAL,31.75
Silver,92.06,ad638da8-366b-481f-995e-fc326301eb16,1.1.7,88.1,81.26,Silver,IBD NIHR BioResource: Contact detail,81.75,02ddc5c9-03d4-40e4-9934-e60817ec8f3e,25.58,HUB > GUT REACTION,28.57
Bronze,60.32,adbee090-9634-455e-9be1-62843158fb08,1.1.7,69.05,74.06,Bronze,Cardiff School of Dentistry Tooth Bank,69.84,0d4f0103-82d8-43f4-8058-4aec80ea562f,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Silver,96.83,adce90ad-d576-4c98-9de9-dca19f7f4d41,1.1.7,92.86,83.64,Silver,North West London Admitted Patient Care Data (NWL APC),84.13,788857b5-6a5b-4ec2-825e-d965e291cf45,25.58,HUB > DISCOVER NOW,28.57
Bronze,60.32,ae2022bc-2083-4e57-b825-1fb610d910ee,1.1.7,69.05,74.06,Bronze,Biobank for patients with retinal degenerations & dystrophies,69.84,cee932f8-151c-4834-ac6d-61d842f9d170,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,41.27,ae4b8371-d037-46e8-bdcd-bf3de08ef38e,1.1.7,50.0,63.37,Not Rated,Optimum Patient Care Research Database,57.94,e3ca35c1-b2e2-4479-adf1-6a78b1c8c088,23.26,HUB > BREATHE,25.4
Silver,100.0,ae788191-69e5-4a03-b11b-bd25574b0e4f,1.1.7,95.24,83.66,Silver,Cystic Fibrosis Patient NTM culture,81.75,69bdac5f-bb70-4ca5-a5ce-51a6106ad00b,27.91,ALLIANCE > CYSTIC FIBROSIS TRUST,36.51
Not Rated,15.87,ae9e8a9f-533f-4823-8e00-84e39ad2c266,1.1.7,19.05,38.59,Not Rated,Community Services Dataset,37.3,cae0a9a5-1bf2-49c3-b8d1-c315d3239074,41.86,ALLIANCE > BARTS HEALTH,41.27
Not Rated,22.22,aeb2f1ea-c914-4b30-94c8-9fd3eb51b288,1.1.7,26.19,47.98,Not Rated,National Audit of Care at the End of Life - Quality Survey,45.23,51a8dfba-5c94-48bd-9c68-3707f0ebc2a2,30.23,ALLIANCE > HQIP,31.75
Not Rated,50.79,aecc1328-3c30-4eff-9f56-ae1278846ef9,1.1.7,57.14,66.94,Bronze,Accelerometer,64.28,ceab57e8-1e13-499b-a8f4-6ad60dad3721,23.26,ALLIANCE > UK BIOBANK,22.22
Bronze,55.56,af238430-c257-4d60-9ff0-1de6b825f09e,1.1.7,64.29,72.84,Bronze,Community perception on public health measures for COVID-19 prevention/control,67.47,6464fb4f-2838-495b-9963-4001204ed166,18.6,HUB > BREATHE,20.63
Bronze,63.49,af2b3e6d-718e-464a-8c0d-5882fa1d869f,1.1.7,71.43,75.25,Bronze,Manchester Cancer Research Centre (MCRC) Biobank,71.43,095d805c-4b62-4726-b968-bb2f1c463701,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,63.49,af2ecff2-398c-437f-8c45-adef2406ce43,1.1.7,71.43,75.25,Bronze,Cardiff University Biobank,71.43,097540aa-a0ed-492e-853b-9ebcfd061dea,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Silver,87.3,af434b05-52a7-4ff1-92f5-e2dd38a574aa,1.1.7,80.95,80.01,Silver,Scottish Birth Record (SBR),81.75,,20.93,ALLIANCE > PUBLIC HEALTH SCOTLAND,23.81
Bronze,60.32,af4af5cc-a9eb-4e0e-b50a-3cab4ac2daf9,1.1.7,69.05,74.06,Bronze,NIHR Exeter Clinical Research Facility,69.84,df9b7bb1-1b26-4e67-b885-df2dcb8e3450,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Gold,95.24,afc8af43-d6cd-4faa-b204-8fc471119b98,1.1.7,90.48,85.94,Silver,National Neonatal Research Database,86.51,67020745-9def-4c6e-b5ac-bb273bd0a20e,18.6,ALLIANCE > NEONATAL DATA ANALYSIS UNIT - IMPERIAL COLLEGE LONDON,22.22
Silver,87.3,b02e2091-f48a-4d50-91a0-de8c76f76c18,1.1.7,80.95,74.19,Bronze,HES Diagnostic Imaging Dataset for CPRD GOLD,76.98,a1bef3a6-9700-43a5-8f3e-dad44ce1fe10,32.56,ALLIANCE > CPRD,33.33
Silver,84.13,b15760f3-e188-446f-aee5-c38bd3859dd4,1.1.7,76.19,72.98,Bronze,Covid-19 Second Generation Surveillance System,76.19,fede31c6-a9c5-4cfb-9866-9b58b2199cff,30.23,ALLIANCE > NHS DIGITAL,31.75
Not Rated,17.46,b1dc1917-8522-4ecd-a829-c866c5cffe3b,1.1.7,21.43,40.95,Not Rated,Tayside Radiology,39.68,af10ec29-1866-4726-b33f-3948afe182f2,39.53,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,38.1
Not Rated,34.92,b27afede-a51d-4aae-8bf7-ce94888fe898,1.1.7,38.1,55.09,Not Rated,Primary-care data,54.76,439e71c7-33b5-4e85-98ce-4b068f2523ad,27.91,UK Biobank,25.4
Silver,100.0,b2fb79c5-26db-484b-8e93-1c56d7654f57,1.1.7,95.24,83.66,Silver,Cystic Fibrosis Patient Transplants,81.75,bea354e8-c552-41ef-80c2-a76ca5767e4b,27.91,ALLIANCE > CYSTIC FIBROSIS TRUST,36.51
Bronze,100.0,b40777a2-468b-4b45-8b7d-2f62f912e950,1.1.7,95.24,74.36,Bronze,HIC ICU 8.3.2,73.81,4f546f1e-433c-4884-a090-2a4520c878ac,46.51,NIHR Health Informatics Collaborative Critical Care Theme,52.38
Silver,88.89,b43309eb-7860-49b7-9f11-1a7a0fd5532e,1.1.7,80.95,75.36,Bronze,UK Cystic Fibrosis Registry (CYFI),76.19,0628fb77-057d-4838-b80e-18245a8f535d,30.23,ALLIANCE > SAIL,36.51
Silver,100.0,b5033be2-0744-49c5-a398-a4d3ed4e1deb,1.1.7,95.24,83.66,Silver,Cystic Fibrosis Patient Chronic Medication,81.75,0ad31772-0893-4cf7-bab0-683e80302201,27.91,ALLIANCE > CYSTIC FIBROSIS TRUST,36.51
Not Rated,74.6,b53f716d-a5c3-4ad8-a2aa-cae09c12ac18,1.1.7,61.9,55.37,Not Rated,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Episodes,59.52,ef22c16c-c294-46e1-abf9-5204212e9053,51.16,ALLIANCE > NHS DIGITAL,55.56
Silver,90.48,b589b19b-b43f-4344-affb-5d7ea328c909,1.1.7,83.33,76.55,Silver,Radiotherapy Dataset,80.16,f102ca50-d1e4-44ec-924e-be89446652af,30.23,ALLIANCE > SAIL,30.16
Not Rated,44.44,b5c9f4c7-bf48-466f-a4e9-e9053225c0fe,1.1.7,50.0,61.05,Not Rated,Assessing the feasibility and effectiveness of introducing pulse oximetry,57.94,2f36b7b3-e50f-459f-a691-f62dde65e2bd,27.91,HUB > BREATHE,28.57
Gold,93.65,b5ecf3e9-f910-4713-81e0-acd3ca6c1cd9,1.1.7,88.1,84.75,Silver,Prescribing Information System (PIS),86.51,,18.6,ALLIANCE > PUBLIC HEALTH SCOTLAND,20.63
Bronze,77.78,b6e4172d-2efd-467c-b357-c90e4ccb5d9e,1.1.7,69.05,69.41,Bronze,Census-Mortality-Hospital Episodes Linked Data,72.22,6064c3a9-e4f1-411b-8181-f1fdca2ab2b8,30.23,NCS > OFFICE FOR NATIONAL STATISTICS,33.33
Bronze,77.78,b6eececf-6ae4-451e-b41c-4bd245646b47,1.1.7,69.05,68.25,Bronze,COVID antigen testing - Pillar 1,73.02,3abc20ce-3dc6-4715-9de0-56aa97a6f5ec,32.56,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,31.75
Bronze,82.54,b6fbcdaf-6732-4b76-b8ca-3388f67bce47,1.1.7,73.81,71.79,Bronze,SICSAG Daily (Scottish Intensive Care Audit Group),73.02,,30.23,ALLIANCE > PUBLIC HEALTH SCOTLAND,36.51
Gold,100.0,b70900e9-85e9-4dd2-ae4b-02523be4219d,1.1.7,95.24,88.32,Gold,Cafcass England,89.69,8ee61578-e298-423a-be22-cb0438023e5c,18.6,ALLIANCE > SAIL,20.63
Bronze,60.32,b7a352ee-6306-4bd8-b9bc-f2a69fe17d70,1.1.7,69.05,74.06,Bronze,Public Health England Seroepidemiology Unit,69.84,89497432-17e0-49f4-96a4-65ef57d07701,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,60.32,b9642fb3-3bee-491b-8d83-22f9de0fd77f,1.1.7,69.05,72.89,Bronze,ESPAC-TPlus,69.05,47f979bc-da9d-4e9e-9f2b-15e09366db04,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Silver,87.3,b9f460e1-cee9-4f52-b464-26b421886939,1.1.7,80.95,78.84,Silver,Mental Health Inpatient and Day Case - Scottish Morbidity Record (SMR04),81.75,,23.26,ALLIANCE > PUBLIC HEALTH SCOTLAND,23.81
Not Rated,77.78,ba071b0b-5ef4-457b-b194-3a69c2c71a06,1.1.7,64.29,56.57,Not Rated,Mental Health Minimum Dataset v4 (Non-Sensitive) Events,61.11,3adeb2f4-a924-49cb-9537-84a9a4242a62,51.16,ALLIANCE > NHS DIGITAL,55.56
Bronze,53.97,bab944af-e345-4893-8640-a88aaff97c72,1.1.7,61.9,71.65,Bronze,Assessment of ASHA’s workload and its determinants,66.67,1a02bc11-a378-4f9e-82f9-c52674b388bd,18.6,HUB > BREATHE,20.63
Bronze,84.13,bb2cb65c-a599-4fdc-bdfa-908d4433e333,1.1.7,76.19,71.81,Bronze,ECOSS (-/+VE tested patients only),71.43,5542cadc-11a4-4957-bbdd-8a6c46bcfb87,32.56,ALLIANCE > PUBLIC HEALTH SCOTLAND,41.27
Not Rated,44.44,bbdb6bc3-bbf7-4b3e-805a-e16d73b899a7,1.1.7,50.0,61.05,Not Rated,Computational Framework to Interpret Chest X-rays and Diagnose Pneumonia,57.94,cf9bc775-1db7-44e4-9a16-317d5bb063a2,27.91,HUB > BREATHE,28.57
Not Rated,36.51,bcb224fe-592f-4aaf-abd1-ad3e3caa61ff,1.1.7,40.48,58.61,Not Rated,UK Biobank Assessment Centre,57.14,2775b97f-1606-490e-81ef-35bad050434a,23.26,UK Biobank,22.22
Silver,90.48,bd87cdf4-ec39-41f6-bb07-c19f10372840,1.1.7,83.33,77.71,Silver,Education Daily Attendance Dataset,79.37,17056e83-ee5a-4fe7-86e1-f09563256be1,27.91,ALLIANCE > SAIL,31.75
Silver,88.89,bd90290d-d60b-499f-b30d-88332274cc46,1.1.7,80.95,75.36,Bronze,Cancer Patient Experience Survey (CPES) for CPRD GOLD,80.16,a4ecb8df-c72f-4018-8f23-e180c28dfdb6,30.23,ALLIANCE > CPRD,28.57
Not Rated,77.78,bdc17b2c-8b0f-4959-ab9b-e2de32d8a5f9,1.1.7,64.29,56.57,Not Rated,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Events,61.11,3d348613-2d66-4814-a294-7e0c365f43f8,51.16,ALLIANCE > NHS DIGITAL,55.56
Not Rated,22.22,bddcc89d-028f-48a5-b568-7dccd574563b,1.1.7,26.19,47.98,Not Rated,National Joint Registry - Revision Shoulder Replacement dataset,45.23,9623e62b-3c50-44aa-8923-0bbb94e7ad61,30.23,ALLIANCE > HQIP,31.75
Not Rated,22.22,be0e737d-37a2-4af0-ac28-0bb7d3b49a52,1.1.7,23.81,40.98,Not Rated,Outpatient Appointment Dataset,40.47,1c27bfbf-c659-42ff-8afe-d58250b49c07,41.86,ALLIANCE > BARTS HEALTH,41.27
Not Rated,68.25,be1368c6-c97f-4ce0-8322-f97ccb28b9c3,1.1.7,59.52,63.48,Not Rated,Oxford Healthcare Workers,65.87,9de2f365-4c5d-4252-acee-6270b113aa93,32.56,ALLIANCE > OXFORD UNIVERSITY HOSPITALS,36.51
Bronze,60.32,be77a483-2eff-4c05-8091-035fe79b3c8a,1.1.7,69.05,72.89,Bronze,Barts CTU,68.25,22aa219f-f3c8-4a25-822e-aa2504f6f29a,23.26,ALLIANCE > TISSUE DIRECTORY,23.81
Bronze,58.73,be9bf427-d96d-4b1a-b1d1-83bdc3e8790b,1.1.7,69.05,76.38,Silver,4 LMIC Asian Country ChrOnic: estimating respiratory disease burden in adults,69.84,490747bf-b268-41f3-8f35-f6bc4a4bdbfa,16.28,HUB > BREATHE,19.05
Not Rated,49.21,bf083b35-da74-4b82-87d3-203ba60325c6,1.1.7,59.52,68.13,Bronze,NIHR BioResource: Metabolite data,62.7,dec09f2e-a93f-41e2-8217-72431ea4a19e,23.26,ALLIANCE > NIHR BIORESOURCE,23.81
Bronze,80.95,bf563953-2293-4fb4-9842-61f7fdadea57,1.1.7,73.81,69.47,Bronze,Emergency Care Data Set (ECDS),73.02,7749d90e-dd7a-4697-8a9c-666491c64a0c,34.88,ALLIANCE > NHS DIGITAL,34.92
Not Rated,34.92,bf625cfe-c4b2-4ea8-bbe8-1a8873ca4cb9,1.1.7,38.1,56.26,Not Rated,Online questionnaires,55.55,8ef26f38-d1b3-4b24-b80a-717f216c6aea,25.58,UK Biobank,23.81
Not Rated,14.29,bf83ada4-b72e-4789-b177-12a53aa763ea,1.1.7,16.67,37.41,Not Rated,TheatreEvents,36.51,2c6adf80-f30b-46c9-b9d4-fe3e68622469,41.86,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,41.27
Bronze,63.49,c03468f4-ba51-4d9f-a785-f041adb84724,1.1.7,71.43,74.09,Bronze,Daisy Tumour Bank,70.64,b3ec5c18-e339-4bd8-8a59-5a3445a81f16,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Not Rated,23.81,c16605d7-6e6e-4461-bfab-107660e31427,1.1.7,28.57,49.17,Not Rated,Vitamin D supplementation meta-analyses,45.24,2454a964-be58-4d1f-8f9a-ffae9db9129c,30.23,HUB > BREATHE,33.33
Silver,100.0,c1682cb7-8f43-49fa-b66a-0a4a205885d3,1.1.7,95.24,84.83,Silver,Cystic Fibrosis Patient Demographics,84.12,19bc55c2-13d7-4488-a52c-35287483ea4e,25.58,ALLIANCE > CYSTIC FIBROSIS TRUST,31.75
Bronze,57.14,c2548017-7913-40e1-bf98-aaa2e907b0ea,1.1.7,66.67,74.03,Bronze,Assessing the eDPSEEA model in seasonal pollen induced asthma in Islamabad,68.25,bfa012ad-e609-4d15-a824-6d143758ca4d,18.6,HUB > BREATHE,20.63
Bronze,60.32,c2c77d1a-d4d8-40cd-95f3-31912d4bd561,1.1.7,69.05,72.89,Bronze,NICAM: Nilotinib treatment for c-KIT mutated advanced AMM,69.05,ba0edcaf-854d-4907-851a-280b56128b3b,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Gold,100.0,c2ddca9f-f144-437b-ac7a-0a628a50ba1a,1.1.7,95.24,87.16,Gold,Outpatient Referral,87.3,7465c65e-c321-42e9-a2f4-6bc664caf1fc,20.93,ALLIANCE > SAIL,25.4
Silver,87.3,c2e112a0-a198-46b0-9a0c-ec91edfb6839,1.1.7,80.95,75.36,Bronze,National Diabetes Audit,77.78,9a434a5c-563b-4da1-9133-9994960ade54,30.23,ALLIANCE > NHS DIGITAL,31.75
Silver,82.54,c2ebe992-e9e8-4316-a565-20d312aa9ef7,1.1.7,76.19,79.95,Silver,Child Health Systems Programme - 4-5 year review,82.54,5844bde6-628d-4e76-bb56-3534e2728eb6,16.28,ALLIANCE > PUBLIC HEALTH SCOTLAND,17.46
Bronze,63.49,c3b4f4f2-953e-4470-bedd-9d09fd30a508,1.1.7,71.43,74.09,Bronze,TRICON8,70.64,85113a93-89ed-40e3-a479-33b461b91858,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Not Rated,22.22,c3d84dfa-fe3a-4b86-a0f5-efbe45aa93ad,1.1.7,26.19,46.81,Not Rated,Sentinel Stroke National Audit Programme Acute Organisational survey dataset,43.65,fe6a4c83-f46f-4f61-8460-e120fdf8d864,32.56,ALLIANCE > HQIP,34.92
Bronze,77.78,c425c244-3406-4914-acf5-b471b4891ced,1.1.7,69.05,68.25,Bronze,Public Health Research Database (PHRD),69.84,a325f33e-bac8-49af-896f-1e025941dae8,32.56,NCS > OFFICE FOR NATIONAL STATISTICS,38.1
Not Rated,22.22,c5994fae-9c4a-47eb-ba42-85bd76e92879,1.1.7,26.19,46.81,Not Rated,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - contextual data,44.45,4559a14f-563d-4fd2-93ae-27c6c0fd891e,32.56,ALLIANCE > HQIP,33.33
Not Rated,66.67,c66f943f-4307-4486-817c-49f6d8b9fd6b,1.1.7,57.14,62.29,Not Rated,PANTHER study,65.08,596077a9-298b-44cc-aa7a-81f04cf5dcb3,32.56,ALLIANCE > UNIVERSITY OF NOTTINGHAM,36.51
Not Rated,47.62,c6e2fffb-4817-462e-ba7e-ff546728f3d1,1.1.7,54.76,63.42,Not Rated,Exogenous sex steroid hormones and asthma in females of reproductive age,59.53,bc5d6d69-ec03-42fe-a63b-638c25c5258c,27.91,HUB > BREATHE,28.57
Not Rated,77.78,c713773c-e961-400e-b44a-947002deb073,1.1.7,64.29,56.57,Not Rated,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Episodes,61.11,334afc50-a05a-43b9-aa1e-a012a22733e0,51.16,ALLIANCE > NHS DIGITAL,55.56
Bronze,66.67,c78122ae-8be1-40d7-8567-b83059941c16,1.1.7,76.19,75.31,Bronze,SCOT translational sample collection,71.43,b3b790a7-a455-4efb-9c68-60e7131cb836,25.58,ALLIANCE > TISSUE DIRECTORY,23.81
Not Rated,17.46,c8516bb0-e4c5-484f-a370-f49315e3a330,1.1.7,21.43,42.11,Not Rated,Tayside Microbiology: Tests,40.48,826be5be-9977-49f9-b6d1-83ed9de08ebe,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Bronze,60.32,c960ffab-a94c-45e3-96a0-598719acfbf5,1.1.7,69.05,74.06,Bronze,National Diet and Nutrition Survey (NDNS),69.84,f86400cb-7cab-4e34-aab6-57138b6a96c2,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,77.78,c97b8058-a6a4-4c8d-92e1-6e9f4cddd301,1.1.7,64.29,56.57,Not Rated,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Records,61.11,01c88a30-b14d-401e-82bb-165cbde81942,51.16,ALLIANCE > NHS DIGITAL,55.56
Bronze,80.95,ca05a688-c305-4ebd-967f-facb010c29bf,1.1.7,73.81,69.47,Bronze,Secondary Uses Services Payment By Results,73.81,2004c512-f7c9-4995-b820-55f36aa3fad2,34.88,ALLIANCE > NHS DIGITAL,33.33
Silver,100.0,ca2c6ec0-00ce-42fc-a077-88911259576c,1.1.7,95.24,83.66,Silver,Cystic Fibrosis Patient Annual Review Encounters,81.75,11360490-8da3-4a25-bb87-4fcc249b9af5,27.91,ALLIANCE > CYSTIC FIBROSIS TRUST,36.51
Silver,100.0,caa644b6-a50d-455b-bee1-96232443e2b9,1.1.7,95.24,83.66,Silver,Cystic Fibrosis Patient Liver Enzyme,81.75,f72e80fc-dcd3-4457-ae91-dd14449002dd,27.91,ALLIANCE > CYSTIC FIBROSIS TRUST,36.51
Not Rated,22.22,cabb1db1-ee3e-42ce-a40b-468282e2011d,1.1.7,26.19,47.98,Not Rated,National Audit of Care at the End of Life - case note review,45.23,d8c67899-2d81-48c2-8482-31cd33973a36,30.23,ALLIANCE > HQIP,31.75
Not Rated,15.87,cb020c3c-f738-4741-bf6b-3df16611b02e,1.1.7,19.05,38.59,Not Rated,Critical Care Minimum Dataset,37.3,c71fbdc3-0311-4b3f-a9ff-7d2f2c0ba993,41.86,ALLIANCE > BARTS HEALTH,41.27
Bronze,63.49,cb7370a6-a1b0-4473-a32f-ec85ec0155a5,1.1.7,71.43,74.09,Bronze,UKCTOCS Longitudinal Women's Cohort (UKLWC),69.84,e0b951ba-0f7d-4743-9374-b965042accdd,23.26,ALLIANCE > TISSUE DIRECTORY,23.81
Not Rated,22.22,cbda5643-96b7-4914-b990-a872e693ff29,1.1.7,26.19,46.81,Not Rated,National Early Inflammatory Arthritis Audit - organisational survey dataset,43.65,a9ac99fe-32be-40ef-9509-03e6b2713ddf,32.56,ALLIANCE > HQIP,34.92
Not Rated,77.78,cc383a3f-1c47-4b7d-99cf-be8ee0afe401,1.1.7,64.29,56.57,Not Rated,Mental Health Minimum Dataset v4.1 (Sensitive) Records,61.11,c00d5ad2-d5d2-4318-8849-4c2fe52aabd0,51.16,ALLIANCE > NHS DIGITAL,55.56
Bronze,80.95,cca8ff71-fc4e-4544-9345-e87f6c0b3f2d,1.1.7,73.81,69.47,Bronze,RAPID (Hospital Stay Level Data),69.05,1fc57971-5af5-499e-a500-4ffbb087f0c4,34.88,ALLIANCE > PUBLIC HEALTH SCOTLAND,42.86
Bronze,63.49,cde234d0-748b-4df6-a59d-3268cc7e8c1d,1.1.7,73.81,74.12,Bronze,RIO,69.84,18bc81e3-7d99-4152-bd7a-3c90ee7e489d,25.58,ALLIANCE > TISSUE DIRECTORY,23.81
Gold,98.41,ce192e2e-4f31-4bb0-9c1f-5c4173c03011,1.1.7,92.86,85.97,Silver,Postponed Admitted Procedures,86.5,bff94600-a254-4111-82f7-6167084d81ca,20.93,ALLIANCE > SAIL,25.4
Not Rated,15.87,ce1bcddb-a6af-4511-84c6-2a252d3eb202,1.1.7,19.05,38.59,Not Rated,Maternity Services Dataset,37.3,173d07ab-5930-4d19-b3de-dcca193e62fd,41.86,ALLIANCE > BARTS HEALTH,41.27
Silver,96.83,ce896b89-5f4a-407c-bb10-7eec51089458,1.1.7,92.86,82.47,Silver,North West London Community Data (NWL COM),81.75,65dad445-ed81-4005-9f5a-4f8a7164043e,27.91,HUB > DISCOVER NOW,33.33
Gold,100.0,cea328df-abe5-48fb-8bcb-c0a5b6377446,1.1.7,95.24,88.32,Gold,Welsh Demographic Service (WDS),89.69,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d,18.6,ALLIANCE > SAIL,20.63
Silver,92.06,cf1feb84-837e-4f51-8320-6171f4970a5f,1.1.7,85.71,76.57,Silver,Death Registration data for CPRD GOLD,79.37,1d35e229-13eb-4be1-9dae-4752b6c27c4a,32.56,ALLIANCE > CPRD,33.33
Not Rated,22.22,cf3f4336-e52d-4b82-8cc5-647dedaaee57,1.1.7,26.19,46.81,Not Rated,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (clinical),44.45,6c81b082-bdc5-4dcc-838a-e6e52e1be1cb,32.56,ALLIANCE > HQIP,33.33
Bronze,55.56,cf8a9d13-0ee9-494d-b50d-cef39e7823c8,1.1.7,64.29,71.68,Bronze,NIHR BioResource: Full Blood Counts,67.47,c20c2d81-c2d3-47cc-be38-93074467544c,20.93,ALLIANCE > NIHR BIORESOURCE,20.63
Gold,98.41,cfdb9fbd-9f67-435c-b257-6b51430451bb,1.1.7,92.86,85.97,Silver,Referral to Treatment Times,86.5,0bf54842-c1db-4bdb-9f55-c5be490bf758,20.93,ALLIANCE > SAIL,25.4
Bronze,60.32,d006821e-a507-4699-b560-b5d023e09d4b,1.1.7,69.05,74.06,Bronze,Cancer Group CTR Cardiff trials,69.84,cd833805-f0a8-4ddb-a50d-b12695c92120,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,46.03,d05e9c8c-085e-4907-8688-cad494636ed8,1.1.7,35.71,44.6,Not Rated,NHS Tayside and Fife Haematology (Lab Data Restructured),47.62,c294bb01-062b-494e-942b-1efe8cbac3dc,46.51,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,50.79
Bronze,77.78,d0d70526-bcfd-4782-a36b-e81d9d693dd4,1.1.7,69.05,67.09,Bronze,COVID antigen  testing - Pillar 2,70.64,c8f2ee14-2831-445d-a207-2f7f932f4735,34.88,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,36.51
Silver,90.48,d0f5761c-66af-4a1c-81c3-eae0f87724b1,1.1.7,83.33,75.38,Bronze,Death Registration data for CPRD Aurum,78.58,ad8f07ef-a984-449b-8a60-d1dd564cc36d,32.56,ALLIANCE > CPRD,33.33
Gold,98.41,d27f265d-8931-4f76-83a2-cb47189a53f0,1.1.7,92.86,85.97,Silver,Welsh Dispensing Dataset,88.09,50ef6443-ed4b-40f9-97fb-1cfd53be6579,20.93,ALLIANCE > SAIL,22.22
Not Rated,46.03,d2af6a29-291b-4444-a17c-40f4208f1e1b,1.1.7,33.33,38.76,Not Rated,Patient Reported Outcome Measures,43.65,55614ed3-2484-4408-a4e9-e5fffed9e8e4,55.81,ALLIANCE > NHS DIGITAL,58.73
Silver,100.0,d2da2750-7482-4ce9-ae5c-2ab393408a67,1.1.7,95.24,84.83,Silver,Education - Wales,84.12,204fa806-071d-4410-9c2c-143017d32d24,25.58,ALLIANCE > SAIL,31.75
Not Rated,22.22,d3673b75-ec8f-4c2e-8c9b-6ef1d951f978,1.1.7,26.19,46.81,Not Rated,Sentinel Stroke National Audit Programme Clinical Dataset,43.65,059a6495-a7d5-435b-8e2b-806c6ccccf2e,32.56,ALLIANCE > HQIP,34.92
Not Rated,52.38,d3e859ba-cfb0-4eda-a14c-34b08d113cd9,1.1.7,59.52,69.3,Bronze,Strategy introducing Pulmonary Rehabilitation for COPD management in rural India,65.08,e8afaf39-86fa-4085-a075-6118cc25fae0,20.93,HUB > BREATHE,22.22
Not Rated,14.29,d3fd4dac-2d15-401c-8185-905ee108d9ce,1.1.7,16.67,38.57,Not Rated,JANUS,37.3,6590f79d-cfea-4695-9fe0-dc5f85e6d273,39.53,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.68
Silver,92.06,d441348a-6121-4e77-b4fb-d14966dc7a3e,1.1.7,85.71,80.06,Silver,National Records of Scotland (NRS) - Deaths Data,78.57,e600dae2-a83c-4b7a-8d23-af4ac31ca374,25.58,ALLIANCE > PUBLIC HEALTH SCOTLAND,34.92
Bronze,57.14,d5446d68-2fb9-4f0f-962e-7b7ed484d534,1.1.7,66.67,74.03,Bronze,Exploration of Pneumonia Related Policy Formation and Implementation in Pakistan,68.25,e0d00cb7-62e1-4a38-8df6-cf537b59228d,18.6,HUB > BREATHE,20.63
Not Rated,14.29,d57a096a-4fa3-4529-b508-0b9df0f1893c,1.1.7,16.67,38.57,Not Rated,OUH Patient Master Index,37.3,5d7465f6-ced8-434b-9907-d357ad125024,39.53,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.68
Not Rated,42.86,d58d02f1-47c2-44fc-b16e-4f6cbbb46e62,1.1.7,47.62,61.02,Not Rated,INTERVAL,59.52,c1fa9b47-a954-4587-a0c2-bae0f3ec2b9b,25.58,OTHER > The University of Cambridge,23.81
Not Rated,61.9,d614f4fc-fae9-4775-86d9-4d4710017cf4,1.1.7,52.38,59.91,Not Rated,TRACK-COVID,62.7,9e89af6b-bfa8-43dc-a2d4-5540c899a670,32.56,OTHER > UNIVERSITY OF CAMBRIDGE,36.51
Bronze,60.32,d6296f3e-ccd9-46a5-acc9-50eb5aa41c56,1.1.7,69.05,72.89,Bronze,UNIRAD UK Sample collection,69.05,a1d16f3f-c7e7-41c5-a071-07889bf49ab1,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Silver,96.83,d711d67c-7f48-4f9c-b482-ac3ed83f7990,1.1.7,92.86,84.8,Silver,IBD NIHR BioResource: Demographic,84.92,b4121feb-f91b-4e20-a19b-fa49c7a5c1c1,23.26,HUB > GUT REACTION,26.98
Bronze,76.19,d713a287-51b6-4951-a479-9a491348c83f,1.1.7,66.67,69.38,Bronze,Scottish Covid-19 Vaccination Data,73.02,bcfd3b49-f7f0-489e-bc1b-bcce0bd261f2,27.91,ALLIANCE > PUBLIC HEALTH SCOTLAND,30.16
Silver,90.48,d9da203c-1202-4d54-a580-b5eb84c0810c,1.1.7,83.33,76.55,Silver,South West Primary Care Dataset,78.58,,30.23,HUB > DATA-CAN,33.33
Not Rated,22.22,da4d3e21-3d81-49e9-ada0-6175e2341190,1.1.7,26.19,47.98,Not Rated,National Vascular Registry -  Abdominal Aortic Aneurysm Repair clinical dataset,45.23,fbe1ae63-0c12-48e5-be16-87d6bc7bd179,30.23,ALLIANCE > HQIP,31.75
Gold,100.0,da5098df-414f-48e0-aaa7-7e2277f80eb7,1.1.7,95.24,88.32,Gold,Looked After Children Wales,89.69,cfdafacb-48f0-4ad8-9f20-193a5eec2da4,18.6,ALLIANCE > SAIL,20.63
Bronze,60.32,da9cdc4c-2790-47f4-b4b5-76e87ce450ae,1.1.7,69.05,74.06,Bronze,King's Health Partners Cancer Biobank,69.84,a218d0b4-0273-4a04-ba17-c01dae6dcf33,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Silver,85.71,dad781b9-43c2-4e8b-a377-e6c0f76d1c04,1.1.7,78.57,74.17,Bronze,NIHR BioResource: Sample holding,76.19,56993820-96e4-4a1f-9de1-bad53108c201,30.23,ALLIANCE > NIHR BIORESOURCE,33.33
Silver,90.48,dada485d-2dbd-4e17-ade6-94512210e909,1.1.7,83.33,80.03,Silver,Outpatient Appointments and Attendances - Scottish Morbidity Record (SMR00),83.34,,23.26,ALLIANCE > PUBLIC HEALTH SCOTLAND,23.81
Not Rated,77.78,db113fcd-69a0-4357-9c6d-250085deb3f5,1.1.7,64.29,56.57,Not Rated,Mental Health Minimum Dataset v4.1 (Sensitive) Events,61.11,a1154967-a80e-41da-a9ae-6183584ecf6b,51.16,ALLIANCE > NHS DIGITAL,55.56
Not Rated,46.03,db276c68-93d2-4591-8dba-b1ce4412a1fa,1.1.7,52.38,63.4,Not Rated,Treatment of Bangladeshi children with severe pneumonia,59.52,2f4c56b3-ca6a-4b30-a7f0-d83e68192c5b,25.58,HUB > BREATHE,26.98
Not Rated,17.46,dba474a3-90c4-423d-beb0-5ef79c490d24,1.1.7,21.43,42.11,Not Rated,"NHS Tayside, A&E Drugs given during an A&E visit",40.48,acfbef89-344c-49a5-8079-7344f4316e0f,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Bronze,63.49,dcb4c87b-5884-41c0-b9af-d7d094dd0922,1.1.7,71.43,75.25,Bronze,NHS Greater Glasgow & Clyde Bio-Repository,71.43,762976cc-83d0-4b31-a879-37f87f947406,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,17.46,dd0ae281-e3b1-48fb-ad7a-c46565b577ce,1.1.7,21.43,42.11,Not Rated,"NHS Tayside A&E, Diagnosis dataset during A&E visit",40.48,14a39e96-8ac3-4df3-b42b-07718121c585,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Bronze,60.32,ddbc149a-db56-41de-bd2c-3624149f6e7e,1.1.7,69.05,74.06,Bronze,MesobanK,69.84,b03835b7-7408-49a0-a9aa-ea405f9855c9,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,22.22,ddc965e7-6f52-4eed-bed5-657e3e7bbeac,1.1.7,26.19,47.98,Not Rated,National Vascular Registry Audit Carotid Endarterectomy Clinical Dataset,45.23,f857055b-c29e-4c7f-99ce-65f4ed59648e,30.23,ALLIANCE > HQIP,31.75
Bronze,60.32,ddd49721-ff49-4f68-b3f5-e95a417fb0ac,1.1.7,69.05,74.06,Bronze,NIMRAD-TRANS,69.84,039b55f7-d416-49ab-9bdb-4ff7dbc733df,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,22.22,de19b3ea-2600-4472-85e8-628e7beff76e,1.1.7,26.19,46.81,Not Rated,National Bowel Cancer Audit -  Organisational Survey dataset,44.45,4e232aa8-ad56-4d82-adcc-cd06715a5c45,32.56,ALLIANCE > HQIP,33.33
Bronze,65.08,de4b46f5-1591-442d-a896-6e0d91657c01,1.1.7,73.81,78.77,Silver,Children's Health in London and Luton (CHILL),74.6,722be723-04bd-48b4-923b-e7d393f0c22b,16.28,HUB > BREATHE,15.87
Not Rated,38.1,de794427-edf8-4c9e-b089-9d7b56d01373,1.1.7,42.86,58.64,Not Rated,VIKING GENES,56.35,43636f80-27fd-43d0-8556-d0a2de0cd819,25.58,OTHER > VIKING GENES,25.4
Not Rated,44.44,deef7616-b14d-46d5-8a1f-b9366abc7913,1.1.7,50.0,61.05,Not Rated,The Consequence of Respiratory Syncytial Virus (RSV) Infection in Young Infants,57.94,51d41006-727e-43d4-bdb6-f8b427c295c6,27.91,HUB > BREATHE,28.57
Silver,71.43,def6669b-0fac-485c-84b2-2ea83ec31123,1.1.7,80.95,85.83,Silver,UK Lung Volume Reduction Surgery,80.96,9f98a674-12f6-42f4-b1a5-322b3b75eef1,9.3,HUBS > BREATHE,9.52
Silver,100.0,df23aabd-3e5f-4fc2-aad6-af990cff6f19,1.1.7,95.24,83.66,Silver,Children’s Kidney Cancers - Great Ormond Street Hospital,84.12,3f71bef5-c5a2-400c-a482-2ad30b29a240,27.91,HUB > DATA-CAN,31.75
Silver,95.24,df3cc57d-08ae-4e81-ae79-283d71cf8d95,1.1.7,90.48,81.28,Silver,IBD NIHR BioResource: SNP chip data,80.95,3c749cfc-4008-4916-b64f-969d6a754c0f,27.91,HUB > GUT REACTION,33.33
Silver,88.89,df514642-bf9d-432f-bf15-4d870fe4ae08,1.1.7,80.95,76.52,Silver,School Workforce Annual Census (SWAC),78.57,5692eade-5738-48ed-8527-39be9caaa7b5,27.91,ALLIANCE > SAIL,31.75
Not Rated,55.56,df63e893-f688-4bb4-956c-cc4354bb4001,1.1.7,64.29,71.68,Bronze,Klang Asthma Cohort,65.88,a2eddb27-c8bd-42ae-94f8-2a3026220da3,20.93,HUB > BREATHE,23.81
Not Rated,17.46,dfb14598-b705-48c0-b6ec-4b84fa4ef1d4,1.1.7,21.43,42.11,Not Rated,Tayside Microbiology: Isolations,40.48,eaa4bab0-0501-4511-aa2d-4e4fee0f0bf3,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Bronze,60.32,dfc3205c-3079-4e95-93e2-8a3a3beeea5a,1.1.7,69.05,74.06,Bronze,Generation Scotland,69.84,019fad36-65ea-4d47-8d6d-a47240eeb801,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,22.22,e10660af-b420-4e25-8fc9-ea451da1dcfb,1.1.7,26.19,47.98,Not Rated,National Oesophago-Gastric Cancer Audit - clinical dataset,45.23,306274ee-a098-43cc-b113-2df8116a8703,30.23,ALLIANCE > HQIP,31.75
Silver,85.71,e149e0c4-7edd-4e9c-af9d-2b3b2baef9bd,1.1.7,76.19,70.66,Bronze,Rural-Urban classification for CPRD Aurum,76.98,b7d24b82-f8a4-4838-844c-ecd86ddf5db2,34.88,ALLIANCE > CPRD,31.75
Bronze,76.19,e1fea1a6-976b-4460-babd-a53d1c49f282,1.1.7,69.05,68.25,Bronze,Mortality (Death registration),72.22,59fb436a-f8c3-4d4a-bc76-d4a02904b078,32.56,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,31.75
Not Rated,52.38,e2126f4c-cefc-4600-895d-c049253031e7,1.1.7,59.52,68.13,Bronze,Hospitalised patients with diabetic emergencies & acute diabetic health concerns,65.08,,23.26,HUB > PIONEER,22.22
Silver,85.71,e22f93fb-bc08-44eb-b292-dc2baf0ad343,1.1.7,78.57,75.33,Bronze,Coagulopathies & arterial/venous thrombosis in COVID patients: an OMOP dataset,79.36,dd4629c0-14b6-4cba-8dcf-31ec5fea68bb,27.91,HUB > PIONEER,26.98
Bronze,82.54,e2f18151-1bce-4a54-ab32-af6296abdfda,1.1.7,76.19,72.98,Bronze,NIHR BioResource: Consent records,74.61,1fb479b1-98d4-4d7b-91a2-8368ce3dc77c,30.23,ALLIANCE > NIHR BIORESOURCE,33.33
Bronze,60.32,e3373d01-48c6-49bc-8c9b-827831e525b3,1.1.7,69.05,72.89,Bronze,"Leeds Dental Institute/School of Dentistry Leeds, Skeletal Tissues Bank",69.05,f94168a1-cab8-4211-90e0-38a241609697,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Not Rated,22.22,e38c8d6c-8655-4432-b654-23f89c0bb495,1.1.7,26.19,47.98,Not Rated,National Joint Registry - Primary Ankle Replacement dataset,45.23,b8d009d0-0163-4aaf-8bd6-ad363c859862,30.23,ALLIANCE > HQIP,31.75
Bronze,63.49,e443bc67-bc8a-430b-88a9-d3380cd2ae38,1.1.7,71.43,75.25,Bronze,eLIXIR - Early Life Data Cross-Linkage in Research,71.43,c8cd0645-b728-4c62-84b8-036c1d8763be,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,23.81,e516a359-74a8-4932-b4df-f2cf75eef89d,1.1.7,28.57,49.17,Not Rated,Unified Cohorts Research Network,45.24,cffcf30d-cedb-421b-a5dc-6726633cb99a,30.23,HUB > BREATHE,33.33
Silver,90.48,e6a61d31-d13f-4804-b24c-9966cc40dcc6,1.1.7,83.33,80.03,Silver,Maternity Inpatient and Day Case - Scottish Morbidity Record (SMR02),83.34,,23.26,ALLIANCE > PUBLIC HEALTH SCOTLAND,23.81
Silver,87.3,e6d1012e-4526-4f11-bff0-a24f0afea3aa,1.1.7,80.95,82.34,Silver,Child Health Systems Programme - First Visit,84.92,dec04153-f595-41ce-9d7e-5ef0c3fe8289,16.28,ALLIANCE > PUBLIC HEALTH SCOTLAND,17.46
Bronze,63.49,e7979d81-708d-4657-857c-4ca95d05cda2,1.1.7,71.43,75.25,Bronze,IDRIS Trial,71.43,8437b207-c925-4dd1-9478-5af329cd736e,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,69.84,e79c5f26-deb0-4531-834d-58912c9fe663,1.1.7,61.9,68.16,Bronze,COVID-19 Staff Testing of Antibody Responses Study (Co-STARS),69.84,435bfcda-f378-44f6-9387-042d959eb945,25.58,ALLIANCE > GREAT ORMOND STREET HOSPITAL,30.16
Bronze,85.71,e7fc3bb6-446b-4267-b563-bf6f94e8dee2,1.1.7,76.19,71.81,Bronze,Lifelong Learning Wales Record (LLWR),75.39,cba62a8d-5917-4912-ad4d-340472f7b904,32.56,ALLIANCE > SAIL,34.92
Gold,100.0,ea9fa5fb-928d-4736-8fbf-e3b58a49c6d6,1.1.7,95.24,87.16,Gold,Children Receiving Care and Support Census,87.3,fb3fac03-a428-4b3f-8058-5622e1fd57d8,20.93,ALLIANCE > SAIL,25.4
Not Rated,14.29,eaca9ed1-30b6-4157-8894-8e53efc84849,1.1.7,16.67,38.57,Not Rated,Sunquest,37.3,a80b2567-4755-46f1-bd2a-f3817ce4f10c,39.53,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.68
Bronze,82.54,eaf84760-348c-4a78-bd9f-489a5813276a,1.1.7,76.19,71.81,Bronze,NIHR BioResource: Contact detail,73.81,fc2fcaec-bd5b-4d43-9e0c-2fed36eff0e4,32.56,ALLIANCE > NIHR BIORESOURCE,34.92
Gold,100.0,eba50bb1-e971-4062-8ece-81be39ceca5b,1.1.7,95.24,87.16,Gold,Annual District Death Extract,87.3,15cf4241-abad-4dcc-95b0-8cd7c02be999,20.93,ALLIANCE > SAIL,25.4
Not Rated,46.03,ecb404b5-2fcb-4b91-a86a-f9f8d25b2ebd,1.1.7,35.71,44.6,Not Rated,Deaths General Registrar Office – National Records Scotland,47.62,5362cfea-d554-43ba-916a-4460da39cc0c,46.51,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,50.79
Not Rated,52.38,ecc4daf2-e58a-4ebc-9608-4bc741231fb9,1.1.7,59.52,69.3,Bronze,"Introducing pulse oximetry in IMNCI, primary health facilities in Pune India",65.08,dae5b81c-db28-414b-9328-5596632a8732,20.93,HUB > BREATHE,22.22
Bronze,63.49,ece82228-9af1-4699-a763-b4608908b645,1.1.7,71.43,75.25,Bronze,NHS Grampian Biorepository,71.43,10d0def8-dc03-473f-b60b-4c0dc3642a25,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,60.32,ee4a73ef-fb4e-4926-9fcc-db6b44b1447e,1.1.7,69.05,72.89,Bronze,The PEACE Study,68.25,33b1a989-5f61-412e-bdae-b551c92d1ed6,23.26,ALLIANCE > TISSUE DIRECTORY,23.81
Silver,88.89,ef3fbf5f-a87c-4f63-8d87-4a5f18fb4301,1.1.7,80.95,81.18,Silver,GP Out of Hours,84.13,731dc868-3e79-4722-9b79-6bb8dec9435b,18.6,ALLIANCE > PUBLIC HEALTH SCOTLAND,20.63
Not Rated,15.87,ef727724-6c38-483b-b28d-8e94b5a9d7ac,1.1.7,19.05,38.59,Not Rated,Freetext Dataset,37.3,0f07f939-1265-4e8b-aaa6-d897d254c2f3,41.86,ALLIANCE > BARTS HEALTH,41.27
Not Rated,22.22,efbb3bf4-834b-417e-b002-03fc41715e58,1.1.7,26.19,46.81,Not Rated,National Cardiac Audit Programme - National Heart Failure Audit,43.65,834618f3-0c6d-4ed2-abae-39208c6b3080,32.56,ALLIANCE > HQIP,34.92
Not Rated,49.21,eff41dbc-0ce4-4bfe-b51f-7b2753750332,1.1.7,57.14,69.27,Bronze,The Malaysian Asthma Hajj Study,64.29,8187f77f-65e3-435e-ad7e-d7f22e2fcf80,18.6,HUB > BREATHE,20.63
Silver,90.48,f0fc13b4-f801-4647-82f3-07ed07f26ea0,1.1.7,83.33,76.55,Silver,Welsh Health Survey Dataset,78.58,e4d8edb3-6e8e-435d-9732-60c83027d8f9,30.23,ALLIANCE > SAIL,33.33
Bronze,85.71,f1f17da0-0249-45a8-8491-ba52b43fbf33,1.1.7,78.57,73.0,Bronze,Linked Census and death occurrences,74.6,54095c0e-6faa-4de4-ac26-e2c7ef3cba5c,32.56,NCS > OFFICE FOR NATIONAL STATISTICS,36.51
Bronze,87.3,f2268d4e-0149-4913-9832-0399960eecd4,1.1.7,80.95,74.19,Bronze,North West London Acute Patient level Data (NWL Acute PLD),74.6,0d5a40e6-52c0-43c4-bd9f-f2a803cc8ff6,32.56,HUB > DISCOVER NOW,38.1
Silver,79.37,f25c8ba2-aa2f-4644-b017-b0a2aa76af65,1.1.7,71.43,74.09,Bronze,Labour Force Survey (Household),77.78,0b630200-1e7c-4b19-ad53-bcc8863f7ade,23.26,NCS > OFFICE FOR NATIONAL STATISTICS,23.81
Not Rated,19.05,f29c2012-132d-4994-b5f4-7992d79a0a08,1.1.7,21.43,39.78,Not Rated,Admitted Patient Care Dataset,38.89,b67f0edd-fed2-4d68-a25f-d225759aa3b0,41.86,ALLIANCE > BARTS HEALTH,41.27
Not Rated,15.87,f2b4211b-1af7-46ff-82a3-35b29d1d478e,1.1.7,19.05,38.59,Not Rated,"Problems, Diagnosis and Procedures",37.3,51b41359-1558-48df-9950-88f75ca6ac4c,41.86,ALLIANCE > BARTS HEALTH,41.27
Bronze,63.49,f4915e4b-639c-45ae-9b0f-afab547e1104,1.1.7,71.43,72.93,Bronze,National Joint Registry - Primary Knee Replacement dataset,69.05,d517e6fc-9a88-4647-b787-dcbed3635885,25.58,ALLIANCE > HQIP,25.4
Silver,90.48,f56d5407-4a7e-420e-8479-87b075da2b39,1.1.7,83.33,75.38,Bronze,GPES Data for Pandemic Planning and Research (COVID-19),79.37,696cfc9f-090d-4328-94ac-140760a77c73,32.56,ALLIANCE > NHS DIGITAL,31.75
Not Rated,17.46,f57d92d9-5288-4b4d-9790-49863e8b9232,1.1.7,21.43,42.11,Not Rated,NHS Tayside and Fife Immunology (Extractable),40.48,39055449-c074-4b58-adb2-b1c0d2441c4d,37.21,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,36.51
Not Rated,22.22,f69d1b15-a0b4-461a-8aff-dba56da0791f,1.1.7,26.19,47.98,Not Rated,National Diabetes Inpatient Audit - Harms clinical dataset,45.23,f1471a45-a6f4-4ed7-96b0-56a1af21086e,30.23,ALLIANCE > HQIP,31.75
Gold,100.0,f6aa8836-b437-40b6-bd1e-ae20010048dd,1.1.7,95.24,87.16,Gold,Substance Misuse Dataset,87.3,291c0dd4-0988-42d2-8e0b-878a892add57,20.93,ALLIANCE > SAIL,25.4
Silver,96.83,f6e25ba4-4f7a-436e-a5f9-f0257d45a612,1.1.7,92.86,82.47,Silver,North West London Integrated Care Record (NWL ICR),83.34,602d8093-6a1e-42cf-a89c-8bf0d47ecc8c,27.91,HUB > DISCOVER NOW,30.16
Bronze,63.49,f71e0f89-edf6-4070-9045-6024b00f79ca,1.1.7,71.43,75.25,Bronze,PHOTO Translational bladder cancer biorepository,71.43,07d1b768-78f6-41e8-995a-66afd2549b34,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,57.14,f73627e3-bd7c-4be2-81b4-3baf846ab787,1.1.7,66.67,70.55,Bronze,Developing and evaluating interventions to improve asthma care: HEAL ASTHMA,65.08,216924f0-585e-4842-a165-78cf9e0af0aa,25.58,HUB > BREATHE,26.98
Not Rated,22.22,f806fe65-79aa-4843-bc56-a08bf14ffcec,1.1.7,26.19,47.98,Not Rated,National Maternity and Perinatal Audit clinical audit,45.23,1419533e-3d46-4d8a-992b-b5311e6bd27b,30.23,ALLIANCE > HQIP,31.75
Bronze,82.54,f80940e8-0ee1-46be-876b-46fb4bbbc4d2,1.1.7,76.19,71.81,Bronze,Medicines dispensed in Primary Care (NHSBSA data),75.4,f201b68f-d995-4a70-a9ee-aa3510232777,32.56,ALLIANCE > NHS DIGITAL,31.75
Not Rated,22.22,f82b8ca5-5a52-4502-bf78-cfbb718cbe2f,1.1.7,26.19,46.81,Not Rated,"Maternal, Newborn and Infant Clinical Outcome Review Programme - perinatal surveillance dataset",44.45,11deee42-5876-4ebe-acca-e996702e1343,32.56,ALLIANCE > HQIP,33.33
Silver,85.71,f87064b0-cb12-4e6e-a709-52e776a0f6b7,1.1.7,78.57,81.14,Silver,Child Health Systems Programme - 13-15 Month Review,84.12,e77af7a3-32fa-4a08-8455-4fb489e5b64a,16.28,ALLIANCE > PUBLIC HEALTH SCOTLAND,17.46
Silver,95.24,f88440b9-53fc-49df-82dd-9cdd3309bd36,1.1.7,90.48,80.12,Silver,IBD NIHR BioResource: Case report form,80.16,877a7275-b99d-4ed4-9691-de577e0ab49e,30.23,HUB > GUT REACTION,34.92
Not Rated,50.79,f88fa262-525a-4d8a-94bd-cb6f5e7efbf7,1.1.7,59.52,68.13,Bronze,Wellcome Sanger Institute: Whole Exome Sequencing,64.28,cd20517c-2f75-40e9-9ee8-563d32624b55,23.26,HUB > GUT REACTION,22.22
Silver,84.13,f8a268c1-831c-4c80-b62c-e254a572b9a0,1.1.7,76.19,74.14,Bronze,Ventilation strategies for patients on intensive care,78.57,1a66dbc1-4f06-455c-85fc-68b372575cad,27.91,HUB > PIONEER,26.98
Not Rated,17.46,f93aea28-7592-42c0-a5e7-5802f0d6051f,1.1.7,19.05,42.09,Not Rated,UK Longitudinal Linkage Collaboration (UK LLC),41.27,d858cd90-9a2f-4330-9bbe-46e047a5d0a2,34.88,OTHER > UK Longitudinal Linkage Collaboration (UK LLC),34.92
Not Rated,36.51,f9959c00-c063-4fbf-933d-755e3b6ecedc,1.1.7,40.48,56.28,Not Rated,Real-time Assessment of Community Transmission (REACT) Study 2: COVID antibody,54.77,70656016-c1c9-4bc2-93d1-c66341fcdf36,27.91,ALLIANCE > IMPERIAL COLLEGE LONDON,26.98
Bronze,63.49,f99d82da-13eb-42db-ad0d-348be2173535,1.1.7,71.43,75.25,Bronze,Tommy's National Reproductive Health Biobank,71.43,20639743-9a28-43dd-a8af-7571ece2a7f8,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,63.49,f9c40294-92d8-45cd-b11a-70eb0fc09004,1.1.7,71.43,74.09,Bronze,PHOENIX DDR-Anti-PD-L1 Trial,70.64,df94730b-374b-4d91-8116-1c10a7c77c4e,23.26,ALLIANCE > TISSUE DIRECTORY,22.22
Not Rated,25.4,fa179e24-2068-4c34-b73c-230003010e9f,1.1.7,30.95,48.04,Not Rated,Genvasc Primary Care Data,45.24,f397acff-a7af-4062-8e8b-c85889cc41df,34.88,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,34.92
Not Rated,22.22,faf7ec31-999a-4d87-9d6d-8837ff2fa486,1.1.7,26.19,46.81,Not Rated,National Cardiac Audit Programme - National Adult Cardiac Surgery Audit (NACSA),43.65,5f37e3c2-b5ac-43eb-8eba-ac94dbbff103,32.56,ALLIANCE > HQIP,34.92
Not Rated,47.62,fb274dd9-27ab-4eac-9432-90373a9837e6,1.1.7,57.14,65.78,Not Rated,NIHR BioResource: Returned datasets,61.11,261bcf76-8621-4f0d-b2e6-310993d73daa,25.58,ALLIANCE > NIHR BIORESOURCE,25.4
Not Rated,38.1,fb2a851b-3f1c-4665-bbdb-5461f1f36bca,1.1.7,42.86,56.31,Not Rated,Hospital Inpatient data,55.56,97c68424-dc80-4faa-b777-67c42f92a9b6,30.23,UK Biobank,26.98
Gold,100.0,fb4a069b-fd74-47b2-bbb1-9cde6b590d66,1.1.7,95.24,88.32,Gold,Breast Test Wales,89.69,8b9efd45-f56d-4aa3-b2b8-c66ff3813a2b,18.6,ALLIANCE > SAIL,20.63
Not Rated,52.38,fbad23e8-5079-4f11-b8b7-aaa01c0fbc4b,1.1.7,61.9,68.16,Bronze,NIHR BioResource: Whole Genome Sequencing,63.49,ecb90b4a-6f4f-4398-a4f6-d64891c4a137,25.58,ALLIANCE > NIHR BIORESOURCE,25.4
Silver,96.83,fc704af0-368b-4dd0-866f-753b6d1dccf8,1.1.7,92.86,83.64,Silver,North West London High Cost Drugs Data (NWL HCD),82.54,75638d2c-556a-46b6-afcc-7ab425b34679,25.58,HUB > DISCOVER NOW,31.75
Not Rated,14.29,fc7b44f0-eb69-4257-8c07-7516c1210c46,1.1.7,16.67,38.57,Not Rated,CellPath,37.3,c4538af4-505f-45df-aeae-788ddfd7cb54,39.53,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,39.68
Bronze,60.32,fd2317ea-c729-433b-b578-309118118b78,1.1.7,69.05,74.06,Bronze,Infectious Diseases BioBank at King's College London,69.84,47b544f4-301c-43e0-b347-fc623ea1a8b3,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Silver,87.3,fd296ed6-6e12-49ab-9e5f-f40428a47b02,1.1.7,80.95,74.19,Bronze,MSDS (Maternity Services Data Set),76.98,11d3cf0f-ae5d-42f4-a756-b98c3eff46bc,32.56,ALLIANCE > NHS DIGITAL,33.33
Not Rated,36.51,fdb053d7-375a-4422-aa16-c899661d72b1,1.1.7,45.24,58.67,Not Rated,"Projections of global, regional and national prevalence of asthma from 2018-2040",53.17,0911f991-6c0f-4412-b805-1ee0ded93a12,27.91,HUB > BREATHE,30.16
Bronze,60.32,fe3f2246-aec4-4be4-8f51-3e5bde80931d,1.1.7,69.05,74.06,Bronze,Bristol Biobank,69.84,9d56ae46-5955-4f03-a93c-a4a6d9f641ab,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,22.22,fe4662ad-9080-4bd8-8de4-51195d275d5b,1.1.7,26.19,47.98,Not Rated,National Joint Registry - Primary Shoulder Replacement dataset,45.23,0e903b9e-a329-478a-937c-480eecee4996,30.23,ALLIANCE > HQIP,31.75
Not Rated,22.22,fe872375-2401-4de1-9650-d4139cf5793a,1.1.7,26.19,45.66,Not Rated,National Paediatric Diabetes Audit - Parent and Patient Recorded Experience measures,42.86,b0979e07-3331-408f-853b-5eeba80ce8f9,34.88,ALLIANCE > HQIP,36.51
Silver,95.24,fed0d62b-f7f7-475c-89c9-67caa374f970,1.1.7,88.1,77.77,Silver,UHB 100K Genomics patient clinical data including their acute care contacts,80.95,ceae4fe0-4e98-4e3c-85db-e86539aade81,32.56,HUB > PIONEER,33.33
Bronze,60.32,fede80e2-aea9-4229-8024-39b09110be7b,1.1.7,69.05,74.06,Bronze,REQUITE,69.84,b5217dcb-582f-4914-ae45-9eb3899add30,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Not Rated,77.78,ff2c6982-00f3-4483-9fc2-19b3a7211d8d,1.1.7,64.29,56.57,Not Rated,Mental Health Minimum Dataset v4 (Non-Sensitive) Records,61.11,b9f24f81-bcf2-4e47-8909-0d5414e2d7a4,51.16,ALLIANCE > NHS DIGITAL,55.56
Bronze,63.49,ff8231e5-3ede-4844-a21b-b1d05120e07e,1.1.7,71.43,75.25,Bronze,IMPORT HIGH trial blood samples,71.43,edafebac-9479-4d2c-b44e-349091d5b35b,20.93,ALLIANCE > TISSUE DIRECTORY,20.63
Bronze,55.56,ffc34689-1a81-4f56-9c3f-e62b76d8445b,1.1.7,64.29,72.84,Bronze,Teleconsultation in remote rural India: management of COPD and Asthma,67.47,de496590-26b3-4e74-bc5e-1ff5c83f5b43,18.6,HUB > BREATHE,20.63
